Επιστημονικές δημοσιεύσεις

Δημοσιεύσεις εργασιών 2021

Thrombocytopenia in COVID-19: pathophysiology matters 

Gavriilaki E, Sakellari I, Gavriilaki M, Anagnostopoulos A 

Ann Hematol 2021 Aug;100(8):2139-2140 

Multipathogen-specific T cells against viral and fungal infections 

Papadopoulou A, Koukoulias K, Alvanou M, Kouimtzidis A, Athanasiou E, Savvopoulos N, Markantonatou AM, Siotou E, Vyzantiadis TA, Anagnostopoulos A, Yannaki E 

Bone Marrow Transplant 2021 Jun;56(6):1445-1448 

“Cerberus” T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients 

Koukoulias K, Papayanni PG, Georgakopoulou A, Alvanou M, Laidou S, Kouimtzidis A, Pantazi C, Gkoliou G, Vyzantiadis TA, Spyridonidis A, Makris A, Chatzidimitriou A, Psatha N, Anagnostopoulos A, Yannaki E, Papadopoulou A. 

Front. Immunol 2021 Jan 18;11:608701 

Higher order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169 

Gemenetzi, F. Psomopoulos, A. Carriles, M. Gounari, C. Minici, K. Plevova, L.A. Sutton, M. Tsagiopoulou, P. Baliakas, K. Pasentsis, A. Anagnostopoulos, R. Sandaltzopoulos, R. Rosenquist, F.B. Davi, S. Pospisilova, P. Ghia, K. Stamatopoulos, M. Degano, A. Chatzidimitriou 

Blood 2021 Apr 8;137(14):1895-1904 

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 

Agathangelidis, Α. Chatzidimitriou, K. Gemenetzi, V. Giudicelli, M. Karypidou, K. Plevova, Z.A. Davis, XJ. Yan, S. Jeromin, C. Schneider, L.B. Pedersen, R. Tschumper, LA. Sutton, P. Baliakas, L. Scarfò, E.J. van Gastel, M. Armand, E. Tausch, B. Biderman, C. Baer, D. Bagnara, A. Navarro, A. de Septenville, V. Guido, G. Mitterbauer-Hohendanner, A. Dimovski, C. Brieghel, S. Lawless, M. Meggendorfer, K. Stranska, M. Ritgen, M. Facco, C. Tresoldi, A. Visentin, A. Patriarca, M. Catherwood, L. Bonello, A. Sudarikov, K. Vanura, M. Roumelioti, H. Skuhrova Francova, T. Moysiadis, S.M. Veronese, K. Giannopoulos, L. Mansouri, T. Karan-Djurasevic, R. Sandaltzopoulos, C. Bödör, F. Fais, A.P. Kater, I. Panovska-Stavridis, D. Rossi, S. Alshemmari, P. Panagiotidis, P.A. Costeas, B. Espinet, D. Antic, L. Foroni, M. Montillo, L. Trentin, N. Stavroyianni, G. Gaidano, P. Francia di Celle, C.U. Niemann, E. Campo, A. Anagnostopoulos, C. Pott, K. Fischer, M. Hallek, D.G. Oscier, S. Stilgenbauer, C. Haferlach, D.F. Jelinek, N. Chiorazzi, S. Pospisilova, M.P. Lefranc, S. Kossida, A.W. Langerak, C. Belessi, F. Davi, R. Rosenquist, P. Ghia, K. Stamatopoulos 

Blood 2021 Mar 11;137(10):1365-1376 

Stem cell factor Is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia 

G.I. Gavriilidis, S. Ntoufa, N. Papakonstantinou, K. Kotta, T. Koletsa, E. Chartomatsidou, T. Moysiadis, N. Stavroyianni, A. Anagnostopoulos, E. Papadaki, A.S. Tsiftsoglou, K. Stamatopoulos 

Haematologica 2021 Mar 1;106(3):692-700 

The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia 

Gerousi, F. Psomopoulos, K. Kotta, M. Tsagiopoulou, N. Stavroyianni, A. Anagnostopoulos, A. Anastasiadis, M. Gkanidou, I. Kotsianidis, S. Ntoufa, K. Stamatopoulos 

Cancers (Basel) 2021 Jan 14;13(2):285 

The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes 

Diamantopoulos PT, Symeonidis A, Pappa V, Kotsianidis I, Galanopoulos A, Pontikoglou C, Anagnostopoulos A, Vassilopoulos G, Zikos P, Hatzimichael E, Papaioannou M, Megalakaki A, Repousis P, Kotsopoulou M, Dimou M, Solomou E, Dryllis G, Tsokanas D, Papoutselis MK, Papageorgiou S, Kyrtshonis MC, Kourakli A, Papadaki H, Panayiotidis P, Viniou NA 

Br J Haematol 2021 Mar;192(6):978-987 

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome 

Hoeks M, Bagguley T, van Marrewijk C, Smith A, Bowen D, Culligan D, Kolade S, Symeonidis A, Garelius H, Spanoudakis M, Langemeijer S, Roelofs R, Wiegerinck E, Tatic A, Killick S, Panagiotidis P, Stanca O, Hellström-Lindberg E, Cermak J, van der Klauw M, Wouters H, van Kraaij M, Blijlevens N, Swinkels DW, de Witte T, EUMDS Registry Participants (A Anagnostopoulos) 

Leukemia 2021 Jun;35(6):1745-1750 

Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome: Disappearance of cytogenetic abnormalities 

Vyrides N, Douka V, Gavriilaki E, Papaioannou G, Athanasiadou A, Neofytou S, Vyrides Y, Lalayanni C, Anagnostopoulos A, Kokoris SI 

Cancer Genet 2021 Jan;250-251:1-5 

In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model 

Li C, Wang H, Georgakopoulou A, Gil S, Yannaki E, Lieber A 

Mol Ther 2021 Feb 3;29(2):822-837 

Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: A systematic review and meta-analysis 

Gavriilaki M, Anyfanti P, Nikolaidou B, Lazaridis A, Gavriilaki E, Douma S, Gkaliagkousi E 

J Clin Hypertens (Greenwich) 2021 May;51(4):1138-1143 

Repeated negative serological testing in otherwise healthy patients with COVID-19 

Chatzidimitriou M, Chatzopoulou F, Gavriilaki E, Chatzivasileiou P, Rousis D, Meletis G, Chatzidimitriou D 

J Infect Dis 2021 Mar 3;223(5):924-926 

Hypertension in rheumatic diseases: prevalence, awareness, treatment, and control rates according to current hypertension guidelines 

Anyfanti P, Gkaliagkousi E, Triantafyllou A, Koletsos N, Gavriilaki E, Galanopoulou V, Aslanidis S, Douma S 

J Hum Hypertens 2021 May;35(5):419-427 

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy 

Ν. Ioannou, PR. Hagner, M. Stokes, AK. Gandhi, B. Apollonio, M. Fanous, D. Papazoglou, LA. Sutton, R. Rosenquist, RM. Amini, H. Chiu, A. Lopez-Girona, P. Janardhanan, FT. Awan, JA. Jones, NE. Kay, TD. Shanafelt, MS. Tallman, K. Stamatopoulos, PE. Patten, A. Vardi, AG. Ramsay 

Blood 2021 Jan 14;137(2):216-231 

Detection of two novel alleles, HLA-A*02:943 and -B*51:104:02, in Greek cord blood units 

Xagorari A, Zamanakou M, Vatsiou S, Papaioannou D, Germenis AE., Sotiropoulos D. 

HLA 2021 Mar;97(3):214-215 

Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation 

E Gavriilaki, I Sakellari, T Chatzikonstantinou, D Mallouri, I Batsis, E Katsifa, S Papadimitriou, A Panteliadou, E Baldoumi, C Demosthenous, Z Bousiou, V Constantinou, D Sotiropoulos, A Anagnostopoulos 

Front Med (Lausanne) 2021 Feb 4;7:608165 

Reinforcing the Immunocompromised Host Defense against Fungi: Progress beyond the Current State of the Art 

Karavalakis G, Yannaki E, Papadopoulou A 

J Fungi (Basel) 2021 Jun 6;7(6):451. doi: 10.3390/jof7060451 

Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients 

Papayanni PG, Chasiotis D, Koukoulias K, Georgakopoulou A, Iatrou A, Gavriilaki E, Giannaki C, Bitzani M, Geka E, Tasioudis P, Chloros D, Fylaktou A, Kioumis I, Triantafyllidou M, Dimou-Besikli S, Karavalakis G, Boutou AK, Siotou E, Anagnostopoulos A, Papadopoulou A, Yannaki E 

Clin Infect Dis 2021 Dec 6;73(11):2073-2082 

Non-transplantable cord blood units as a source for adoptive immunotherapy of leukaemia and a paradigm of circular economy in medicine 

Koukoulias K, Papadopoulou A, Kouimtzidis A, Papayanni PG, Papaloizou A, Sotiropoulos D, Yiangou M, Costeas P, Anagnostopoulos A, Yannaki E, Kaloyannidis P 

Br J Haematol 2021 Jul;194(1):158-167 

Success Stories and Challenges Ahead in Hematopoietic Stem Cell Gene Therapy: Hemoglobinopathies as Disease Models 

Yannaki E, Psatha N, Papadopoulou A, Athanasopoulos T, Gravanis A, Roubelakis MG, Tsirigotis P, Anagnostopoulos A, Anagnou NP, Vassilopoulos 

Hum Gene Ther 2021 Oct;32(19-20):1120-1137 

Genetic justification of severe COVID-19 using a rigorous algorithm 

Gavriilaki E, Asteris PG, Touloumenidou T, Koravou EE, Koutra M, Papayanni PG, Karali V, Papalexandri A, Varelas C, Chatzopoulou F, Chatzidimitriou M, Chatzidimitriou D, Veleni A, Grigoriadis S, Rapti E, Chloros D, Kioumis I, Kaimakamis E, Bitzani M, Boumpas D, Tsantes A, Sotiropoulos D, Sakellari I, Kalantzis IG, Parastatidis ST, Koopialipoor M, Cavaleri L, Armaghani DJ, Papadopoulou A, Brodsky RA, Kokoris S, Anagnostopoulos A 

Clin Immunol 2021 May;226:108726 

Complement in Sickle Cell Disease: Are We Ready for Prime Time? 

Varelas C, Tampaki A, Sakellari I, Anagnostopoulos Α, Gavriilaki E, Vlachaki E. J Blood Med 2021 Mar 23;12:177-187 

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD) 

Demosthenous C, Sakellari I, Douka V, Papayanni PG, Anagnostopoulos A, Gavriilaki E 

J Clin Med 2021 May 11;10(10):2050 

Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis 

Eftychidis I, Sakellari I, Anagnostopoulos A, Gavriilaki E 

Expert Rev Hematol 2021 Sep;14(9):831-840 

Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease 

Gavriilaki E, Sakellari I, Chatzikonstantinou T, Bousiou Z, Mallouri D, Masmanidou M, Vardi A, Koravou EE, Kika F, Touloumenidou T, Papalexandri A, Yannaki E, Batsis I, Anagnostopoulos A 

Transplant Proc 2021 Sep;53(7):2261-2266 

Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid Malignancies 

Sakellari I, Gavriilaki E, Mallouri D, Batsis I, Varelas C, Tagara S, Bousiou Z, Papathanasiou M, Vardi A, Papalexandri A, Vadikoliou C, Athanasiadou A, Lalayanni C, Fylaktou A, Antoniadis K, Anagnostopoulos A 

Transplant Cell Ther 2021 Nov;27(11):916.e1-916.e6 

Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo 

Psatha N, Georgakopoulou A, Li C, Nandakumar V, Georgolopoulos G, Acosta R, Paschoudi K, Nelson J, Chee D, Athanasiadou A, Kouvatsi A, Funnell APW, Lieber A, Yannaki E, Papayannopoulou T 

Blood 2021 Oct 28;138(17):1540-1553 

Myasthenia gravis genome-wide association study implicates AGRN as a risk locus 

Topaloudi A, Zagoriti Z, Flint AC, Martinez MB, Yang Z, Tsetsos F, Christou YP, Lagoumintzis G, Yannaki E, Zamba-Papanicolaou E, Tzartos J, Tsekmekidou X, Kotsa K, Maltezos E, Papanas N, Papazoglou D, Passadakis P, Roumeliotis A, Roumeliotis S, Theodoridis M, Thodis E, Panagoutsos S, Yovos J, Stamatoyannopoulos J, Poulas K, Kleopa K, Tzartos S, Georgitsi M, Paschou P 

J Med Genet 2021 Aug 16:jmedgenet-2021-107953 

Investigating the Barrier Activity of Novel, Human Enhancer-Blocking Chromatin Insulators for Hematopoietic Stem Cell Gene Therapy 

Papayanni PG, Psatha N, Christofi P, Li XG, Melo P, Volpin M, Montini E, Liu M, Kaltsounis G, Yiangou M, Emery DW, Anagnostopoulos A, Papayannopoulou T, Huang S, Stamatoyannopoulos G, Yannaki E 

Hum Gene Ther 2021 Oct;32(19-20):1186-1199 

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial 

Moreau P, Dimopoulos MA, Mikhael J, Yong K, Capra M, Facon T, Hajek R, Špička I, Baker R, Kim K, Martinez G, Min CK, Pour L, Leleu X, Oriol A, Koh Y, Suzuki K, Risse ML, Asset G, Macé S, Martin T; IKEMA study group (Anagnostopoulos A) 

Lancet 2021 Jun 19;397(10292):2361-2371 

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease 

Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators (Anagnostopoulos A) 

N Engl J Med 2021 Jul 15;385(3):228-238 

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial 

Döhner H, Symeonidis A, Deeren D, Demeter J, Sanz MA, Anagnostopoulos A, Esteve J, Fiedler W, Porkka K, Kim HJ, Lee JH, Usuki K, D’Ardia S, Won Jung C, Salamero O, Horst HA, Recher C, Rousselot P, Sandhu I, Theunissen K, Thol F, Döhner K, Teleanu V, DeAngelo DJ, Naoe T, Sekeres MA, Belsack V, Ge M, Taube T, Ottmann OG 

Hemasphere 2021 Aug 2;5(8):e617 

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study 

Lawless S, Sbianchi G, Morris C, Iacobelli S, Bosman P, Blaise D, Reményi P, Byrne JL, Mayer J, Apperley J, Lund J, Kobbe G, Schaap N, Isaksson C, Lenhoff S, Basak G, Touzeau C, Wilson KMO, González Muñiz S, Scheid C, Browne P, Anagnostopoulos A, Rambaldi A, Jantunen E, Kröger N, Schönland S, Yakoub-Agha I, Garderet L 

Clin Lymphoma Myeloma Leuk 2021 Oct;21(10):686-693 

RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia 

Ntoufa S, Gerousi M, Laidou S, Psomopoulos F, Tsiolas G, Moysiadis T, Papakonstantinou N, Mansouri L, Anagnostopoulos A, Stavrogianni N, Pospisilova S, Plevova K, Makris AM, Rosenquist R, Stamatopoulos K 

Blood Adv 2021 Jul 13;5(13):2788-2792 

Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing 

Tampaki A, Gavriilaki E, Varelas C, Anagnostopoulos A, Vlachaki E 

Blood Rev 2021 Jul;48:100805 

Stem cell factor is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia 

Gavriilidis GI, Ntoufa S, Papakonstantinou N, Kotta K, Koletsa T, Chartomatsidou E, Moysiadis T, Stavroyianni N, Anagnostopoulos A, Papadaki E, Tsiftsoglou AS, Stamatopoulos K 

Haematologica 2021 Mar 1;106(3):692-700 

The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia 

Gerousi M, Psomopoulos F, Kotta K, Tsagiopoulou M, Stavroyianni N, Anagnostopoulos A, Anastasiadis A, Gkanidou M, Kotsianidis I, Ntoufa S, Stamatopoulos K 

Cancers (Basel) 2021 Jan 14;13(2):285 

6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150) 

Wei AH, Panayiotidis P, Montesinos P, Laribi K, Ivanov V, Kim I, Novak J, Stevens DA, Fiedler W, Pagoni M, Bergeron J, Ting SB, Hou JZ, Anagnostopoulos A, McDonald A, Murthy V, Yamauchi T, Wang J, Chyla B, Sun Y, Jiang Q, Mendes W, Hayslip J, DiNardo CD 

Blood Cancer J 2021 Oct 1;11(10):163 

Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond 

Gavriilaki E, Peffault de Latour R, Risitano AM 

Blood 2021 Sep 5:blood.2021012860 

Molecular Advances in Hypertension and Blood 

Gavriilaki E, Gkaliagkousi E 

Int J Mol Sci 2021 Dec 28;23(1):278 

“Long COVID-19” of Researchers: What to Do Next? 

Gavriilaki E, Maiques-Diaz A 

Hemasphere 2021 Dec 22;6(1):e673 

Patient risk stratification and tailored clinical management of post-transplant CMV-, EBV-, and BKV-infections by monitoring virus-specific T-cell immunity 

A Papadopoulou, K Koukoulias, M Alvanou, VK Papadopoulos, Z Bousiou, V. Kalaitzidou, F. Kika, A. Papalexandri, D.  Mallouri, I. Batsis, I. Sakellari, A. Anagnostopoulos, E. Yannaki 

eJHaem 2021 Jun;2(3): 428-439 

Real-world data of thrombotic microangiopathy management: the key role of ADAMTS13 activity and complement testing 

E Gavriilaki, E Koravou, T Chatziconstantinou, C Kalpadaki, N Printza, M Ximeri, A Christoforidou, G Karavalakis, M Kaliou, V Kalaitzidou, I Tassi, M Tzellou, T Touloumenidou, A Papalexandri, M Papathanasiou, A Syrigou, A Kioumi, M Liga, A Anagnostopoulos 

Thrombosis Update 2021, volume 3, 100043 

Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman 

primates using HDAd5/35++ vectors 

Li C, Wang H, Gil S, Germond A, Fountain C, Baldessari A, Kim J, Liu Z, Georgakopoulou A, Radtke S, Raskó T, Pande A, Chiang C, Chin E, Yannaki E, Izsvák Z, Papayannopoulou T, Kiem HP, Lieber A 

Mol Ther Methods Clin Dev 2021 Dec 6;24 

In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice 

Li C, Georgakopoulou A, Mishra A, Gil S, Hawkins RD, Yannaki E, Lieber A. 

Blood Adv 2021 Feb 23;5(4):1122-1135 

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy 

Gavriilaki E, Ho VT, Schwaeble W, Dudler T, Daha M, Fujita T, Jodele S. 

Exp Hematol Oncol 2021 Dec 19;10(1):57 

The International Hemoglobinopathy Research Network (INHERENT): an international initiative to study the role of genetic modifiers in hemoglobinopathies 

Kountouris P, Stephanou C, Archer N, Bonifazi F, Giannuzzi V, Kuo KHM, Maggio A, Makani J, Del Mar Mañú-Pereira M, Michailidou K, Nkya S, Nnodu OE, Trompeter S, Tshilolo L, Wonkam A, Zilfalil BA, Inusa BPD, Kleanthous M; International Hemoglobinopathy Research Network (INHERENT). 

Am J Hematol 2021 Nov 1;96(11):E416-E420 

Repeated Negative Serological Testing in Otherwise Healthy Patients With Coronavirus Disease 2019 

Chatzidimitriou M, Chatzopoulou F, Gavriilaki E, Chatzivasileiou P, Rousis D, Meletis G, Chatzidimitriou D 

J Infect Dis 2021 Mar 3;223(5):924-926 

Toll-Like Receptors in the Pathogenesis of Essential Hypertension. A Forthcoming Immune-Driven Theory in Full Effect 

Lazaridis A, Gavriilaki E, Douma S, Gkaliagkousi E 

Int J Mol Sci 2021 Mar 26;22(7):3451 

JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature 

Chatzidavid S, Giannakopoulou N, Diamantopoulos PT, Gavriilaki E, Katsiampoura P, Lakiotaki E, Sakellariou S, Viniou NA, Dryllis G 

Thromb J 2021 Mar 10;19(1):16 

A study of endothelial and platelet microvesicles across different hypertension phenotypes 

Lazaridis A, Gavriilaki E, Nikolaidou B, Yiannaki E, Dolgyras P, Anyfanti P, Triantafyllou A, Koletsos N, Tzimos C, Markala D, Douma S, Gkaliagkousi E. 

J Hum Hypertens 2021 Apr 9. Online ahead of print 

Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters 

Nikolaidou B, Anyfanti P, Gavriilaki E, Lazaridis A, Triantafyllou A, Zarifis H, Mastrogiannis K, Tsapas A, Douma S, Gkaliagkousi E 

J Hum Hypertens 2021 Aug 16. Online ahead of print. 

Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas 

Dimou M, Papageorgiou SG, Stavroyianni N, Katodritou E, Tsirogianni M, Kalpadakis C, Banti A, Arapaki M, Iliakis T, Bouzani M, Verrou E, Spanoudakis E, Giannouli S, Marinakis T, Mandala E, Mparmparousi D, Sachanas S, Dalekou- Tsolakou M, Hatzimichael E, Vadikolia C, Violaki V, Poziopoulos C, Tsirkinidis P, Chatzileontiadou S, Vervessou E, Ximeri M, Sioni A, Konstantinidou P, Kyrtsonis MC, Siakantaris MP, Angelopoulou MK, Pappa V, Konstantopoulos K, Panayiotidis P, Vassilakopoulos TP 

Hematol Oncol 2021 Aug;39(3):336-348 

Assessing Patients’ Knowledge on Chronic Lymphocytic Leukemia: Validation of the ERIC CLL Knowledge Questionnaire in Greece 

Karamanidou C, Xochelli A, Papaioannou M, Moysiadis T, Scarfo L, Mattsson M, Stavroyianni N, Rosenquist R, Ghia P, Stamatopoulos K 

Hemasphere 2021 Feb 23;5(3):e546 

MyPal ADULT study protocol: a randomised clinical trial of the MyPal ePRO-based early palliative care system in adult patients with haematological malignancies 

Scarfò L, Karamanidou C, Doubek M, Garani-Papadatos T, Didi J, Pontikoglou C, Ling J, Payne C, Papadaki HΑ, Rosenquist R, Stavroyianni N, Payne S, Ghia P, Natsiavas P, Maramis C, Stamatopoulos K 

BMJ Open. 2021 Nov 2;11(11):e050256 

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study 

Chatzikonstantinou T, Kapetanakis A, Scarfò L, Karakatsoulis G, Allsup D, Cabrero AA, Andres M, Antic D, Baile M, Baliakas P, Bron D, Capasso A, Chatzileontiadou S, Cordoba R, Correa JG, Cuéllar-García C, De Paoli L, De Paolis MR, Del Poeta G, Demosthenous C, Dimou M, Donaldson D, Doubek M, Efstathopoulou M, Eichhorst B, El-Ashwah S, Enrico A, Espinet B, Farina L, Ferrari A, Foglietta M, Frederiksen H, Fürstenau M, García-Marco JA, García- Serra R, Gentile M, Gimeno E, Glenthøj A, Gomes da Silva M, Gutwein O, Hakobyan YK, Herishanu Y, Hernández-Rivas JÁ, Herold T, Innocenti I, Itchaki G, Jaksic O, Janssens A, Kalashnikova ОB, Kalicińska E, Karlsson LK, Kater AP, Kersting S, Labrador J, Lad D, Laurenti L, Levin MD, Lista E, Lopez-Garcia A, Malerba L, Marasca R, Marchetti M, Marquet J, Mattsson M, Mauro FR, Milosevic I, Mirás F, Morawska M, Motta M, Munir T, Murru R, Niemann CU, Rodrigues RN, Olivieri J, Orsucci L, Papaioannou M, Pavlovsky MA, Piskunova I, Popov VM, Quaglia FM, Quaresmini G, Qvist K, Reda G, Rigolin GM, Ruchlemer R, Saghumyan G, Shrestha A, Šimkovič M, Špaček M, Sportoletti P, Stanca O, Stavroyianni N, Tadmor T, Te Raa D, Tonino SH, Trentin L, Van Der Spek E, van Gelder M, van Kampen R, Varettoni M, Visentin A, Vitale C, Wasik Szczepanek E, Wróbel T, San Segundo LY, Yassin M, Coscia M, Rambaldi A, Montserrat E, Foà R, Cuneo A, Stamatopoulos K, Ghia P 

Leukemia 2021 Dec;35(12):3444-3454 

Adenoviral Infections in Bone Marrow Transplanted Adult Patients: A Review of the 44 Cases Reported in the Last 25 Years 

Keramari S, Poutoglidou F, Poutoglidis A, Sotiropoulos D, Savopoulos C, Chlichlia K, Chatzis S, Xagorari A, Kaiafa G 

Cureus, 2021 Nov 24;13(11):e19865 

Solitary extramedullary plasmacytoma of the parotid gland in a patient with mixed connective tissue disease 

Tatsis D, Sotiropoulos D, Baliaka A, Kalaitsidou I 

J Oral Maxillofac Pathol 2021 Mar; 25(Suppl 1): S18–S21 

Pomalidomide Plus LowDose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the RealWorld “POWERFUL” Study 

Terpos, P. Repousis, C. Lalayanni, E. Hatjiharissi, T. Assimakopoulou, G. Vassilopoulos, A. Pouli, E. Spanoudakis, E. Michalis, G. Pangalis, I. Ntanasis‐Stathopoulos, C. Poziopoulos, M‐C. Kyrtsonis, V. Pappa, A. Symeonidis, C. Georgopoulos, P. M. Zikos, M. Gavriatopoulou, H. A. Papadaki, M. Dadakaridou, K. Karvounis‐Marolachakis, E. Katodritou 

Clin. Med 2021, 10, 1509 

Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes 

Liapis K, Papadopoulos V, Vrachiolias G, Galanopoulos AG, Papoutselis M, Papageorgiou SG, Diamantopoulos PT, Pappa V, Viniou NA, Kourakli A, Τsokanas D, Vassilakopoulos TP, Hatzimichael E, Bouronikou E, Ximeri M, Pontikoglou C, Megalakaki A, Zikos P, Panayiotidis P, Dimou M, Karakatsanis S, Papaioannou M, Vardi A, Kontopidou F, Harchalakis N, Adamopoulos I, Symeonidis A, Kotsianidis I 

Blood Cancer J 2021 Feb 11;11(2):30 

Επιπλοκές κυτταρικής θεραπείας με CAR T cells -Παθοφυσιολογία και αντιμετώπιση 

Δημοσθένους Χ, Χατζηκωνσταντίνου Θ, Βαρδή Α 

Haema 2021;12(Suppl 1): 107–113 

Εξελίξεις στη διαφοροδιαγνωστική προσέγγιση και θεραπεία των θρομβωτικών μικροαγγειοπαθειών στην εποχή των στοχευμένων παραγόντων 

Μπούσιου Ζ, Γαβριηλάκη Ε 

Haema 2021;12(Suppl 1): 145–15 

Secondary Acute Myeloid Leukemia (sAML): Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AML 

Lalayanni C, Gavriilaki E, Athanasiadou A, Iskas M, Papathanasiou M, Marvaki A, Mpesikli S, Papaioannou G, Mallouri D, Batsis I, Papalexandri A, Sakellari I, Anagnostopoulos A 

Clin Lymphoma Myeloma Leuk 2022 Apr;22(4):e233-e240. Epub 2021 Oct 1 

A non-interventional study of microcirculation dynamics in allogeneic hematopoietic cell transplantation survivors compared to controls: evidence of impaired microvascular response regardless of conventional cardiovascular risk factors 

Gavriilaki E, Anyfanti P, Sakellari I, Batsis I, Dolgyras P, Lazaridis A, Nikolaidou B, Koletsos N, Gavriilaki M, Zarifis I, Masmanidou M, Bousiou Z, Vardi A, Douma S, Anagnostopoulos A, Gkaliagkousi E 

Bone Marrow Transplant 2022 Jan;57(1):72-77. Epub 2021 Oct 13 

Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion-dependent β-thalassaemia of a severe genotype 

Constantinou V, Papayanni PG, Mallouri D, Batsis I, Bouinta A, Papadopoulou D, Papadimitriou V, Kammenou M, Pantelidou D, Sotiropoulos D, Sakellari I, Anagnostopoulos A, Yannaki E 

Br J Haematol 2022 Mar;196(6):1401-14042021 Dec 27. Epub 2021 Dec 27 

Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares and cardiovascular comorbidities 

Anyfanti P, Gavriilaki E, Nikolaidou B, Yiannaki E, Lazaridis A, Papadopoulos N, Douma S, Doumas M, Gkaliagkousi E 

J Thromb Thrombolysis 2022 Jan;53(1):10-16. Epub 2021 Jul 5

Δημοσιεύσεις εργασιών 2020

Endothelial and complement activation as predictors of survival in adult allogeneic hematopoietic cell transplantation 

Gavriilaki E, Sakellari I, Chatzikonstantinou T, Mallouri D, Batsis I, Vardi A, Bousiou Z, Koravou EE, Masmanidou M, Touloumenidou T, Papalexandri A, Athanasiadou A, Yannaki E, Anagnostopoulos A 

HemaSphere 2020; 5(1): e487 

Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT 

Cesaro S, Tridello G, van der Werf S, Bader P, Sociè G, Ljungman P, McQuaker G, Giardino S, Uckan-Cetinkaya D, Anagnostopoulos A, Ozdogu H, Schots R, Jindra P, Ladetto M, Schroyens W, Mikulska M, Styczynski J 

Bone Marrow Transplant 2020 Jan;55(1):110-116 

Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 

González-Barca E, Boumendil A, Blaise D, Trněný M, Masszi T, Finel H, Michieli MG, Bittenbring JT, Gritti G, Snowden JA, Bishton M, Bruno B, de Villambrosia SG, Janikova A, Leleu X, Anagnostopoulos A, Poiré X, Crysandt M, Özkurt ZN, Vandenberghe E, Itälä-Remes M, Cahn JY, Jantunen E, Schroyens W, Maertens J, Esquirol A, Dreger P, Montoto S, Sureda A 

Bone Marrow Transplant 2020 Feb;55(2):393-399 

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS 

Chaturvedi S, Braunstein EM, Yuan X, Yu J, Alexander A, Chen H, Gavriilaki E, Alluri R, Streif MB, Petri M, Crowther M, McCrae KR, Brodsky RA 

Blood 2020 Jan 23;135(4):239-251 

Kidney Disease after Allogeneic Hematopoietic Cell Transplantation: In Search of the Truth 

Gavriilaki E, Sakellari I 

Acta Haematol 2020;143(5):405-406 

Characteristics of Long-Term Survival in Patients with Myelodysplastic Syndrome Treated With 5-Azacyditine: Results from the Hellenic 5-Azacytidine Registry 

Diamantopoulos PT, Pappa V, Symeonidis A, Kotsianidis I, Galanopoulos A, Papadaki H, Anagnostopoulos A, Vassilopoulos G, Zikos P, Hatzimichael E, Papaioannou M, Megalakaki A, Kotsopoulou M, Repousis P, Dimou M, Solomou E, Pontikoglou C, Kyriakakis G, Tsokanas D, Papoutselis MK, Papageorgiou S, Kourakli A, Panayiotidis P, Viniou NA 

Clin Lymphoma Myeloma Leuk 2020 Feb;20(2):114-121 

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor 

Sureda A, Chabannon C, Masszi T, Pohlreich D, Scheid C, Thieblemont C, Wahlin BE, Sakellari I, Russell N, Janikova A, Dabrowska-Iwanicka A, Touzeau C, Esquirol A, Jantunen E, van der Werf S, Bosman P, Boumendil A, Liu Q, Celanovic M, Montoto S, Dreger P 

Bone Marrow Transplant 2020 Mar;55(3):613-622 

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial 

Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, Kim I, Stevens DA, Fiedler W, Pagoni M, Samoilova O, Hu Y, Anagnostopoulos A, Bergeron J, Hou JZ, Murthy V, Yamauchi T, McDonald A, Chyla B, Gopalakrishnan S, Jiang Q, Mendes W, Hayslip J, Panayiotidis P 

Blood 2020 Jun 11;135(24):2137-2145 

A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma 

Hajek R, Pour L, Ozcan M, Martin Sánchez J, García Sanz R, Anagnostopoulos A, Oriol A, Cascavilla N, Terjung A, Lee Y, Briso EM, Dobkowska E, Hauns B, Špička I 

Eur J Haematol 2020 May;104(5):435-442 

Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy 

Gavriilaki E, Touloumenidou T, Sakellari I, Batsis I, Mallouri D, Psomopoulos F, Tsagiopoulou M, Koutra M, Yannaki E, Papalexandri A, Taylor P, Nikolousis E, Stamouli M, Holbro A, Baltadakis I, Liga M, Spyridonidis A, Tsirigotis P, Charchalakis N, Tsakiris DA, Brodsky RA, Passweg J, Stamatopoulos K, Anagnostopoulos A 

Thromb Haemost 2020;120(4):638-646 

The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis 

Gavriilaki M, Sakellari I, Anagnostopoulos A, Gavriilaki E 

Biol Blood Marrow Transplant 2020; 26(9):1738-1746 

An Update in Drug-Induced Thrombotic Microangiopathy 

Chatzikonstantinou T, Gavriilaki M, Anagnostopoulos A, Gavriilaki E 

Front Med(Lausanne) 2020 May 22;7:212 

A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity 

Gavriilaki E, Sakellari I, Gavriilaki M, Anagnostopoulos A 

Int J Mol Sci 2020;21(11):3886 

Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements 

Wang H, Georgakopoulou A, Li C, Liu Z, Gil S, Bashyam A, Yannaki E, Anagnostopoulos A, Pande A, Izsvák Z, Papayannopoulou T, Lieber A 

JCI Insight 2020 Aug 20;5(16): e139538 

T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities 

Vardi, E. Vlachonikola, D. Papazoglou, F. Psomopoulos, K. Kotta, N. Ioannou, C. Galigalidou, K. Gemenetzi, K. Pasentsis, M. Kotouza, E. Koravou, L. Scarfó, M. Iskas, N. Stavroyianni, P. Ghia, A. Anagnostopoulos, A. Kouvatsi, A.G. Ramsay, K. Stamatopoulos, A. Chatzidimitriou 

Clin Cancer Res 2020 Sep 15;26(18):4958-4969 

Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT 

Martínez C, Boumendil A, Romejko-Jarosinska J, Anagnostopoulos A, Faber E, Poiré X, Yakoub-Agha I, Akhtar S, Gurman G, Pavone V, Halaburda K, Sousa AB, Ghesquières H, Finel H, Khvedelidze I, Montoto S, Sureda A 

Leuk Lymphoma 2020 Dec;61(12):2915-2922 

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 

Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, Szer J, Wagner EM, Zuckerman T, Mahuzier B, Xu J, Wilke C, Gandhi KK, Socié G; REACH2 Trial Group 

Engl J Med. 2020 May 7;382(19):1800-1810 

Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group 

Katodritou E, Kastritis E, Gatt M, Cohen YC, Avivi I, Pouli A, Lalayianni C, Lavi N, Delimpasis S, Kyrtsonis MC, Michael M, Suriu C, Miri Z, Tzafarti K, Vadikoliou C, Maltezas D, Zikos P, Ganzel C, Vaxman Y, Aviv A, Christoforidou A, Gavriatopoulou M, Shaulov A, Verrou E, Papanota AM, Fakinos G, Gkioka AI, Palaska V, Triantafyllou T, Konstantinidou P, Anagnostopoulos A, Terpos E, Dimopoulos MA 

Am J Hematol 2020 May;95(5):465-471 

Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes 

SG. Papageorgiou, I. Kotsianidis, A. Bouchla, A. Symeonidis, A. Galanopoulos, NA. Viniou, E. Hatzimichael, TP. Vassilakopoulos, D. Gogos, A. Megalakaki, P. Zikos, P. Diamantopoulos, A. Kourakli, P. Giannoulia, M. Papoutselis, E. Poulakidas, M. Arapaki, A. Vardi, A. Anagnostopoulos, D. Mparmparousi, M. Papaioannou, E. Bouronikou, M. Dimou, H. Papadaki, P. Panayiotidis, V. Pappa 

Ther Adv Hematol 2020;11: 2040620720966121 

Age-, sex- and disease subtype-related foetal growth differentials in childhood acute myeloid leukaemia risk: A Childhood Leukemia International Consortium analysis 

Karalexi MA, Dessypris N, Ma X, Spector LG, Marcotte E, Clavel J, Pombo-deOliveira MS, Heck JE, Roman E, Mueller BA, Hansen J, Auvinen A, Lee PC, Schüz J, Magnani C, Mora AM, Dockerty JD, Scheurer ME, Wang R, Bonaventure A, Kane E, Doody DR; NARECHEM-ST Group; FRECCLE Group, Erdmann F, Kang AY, Metayer C, Milne E, Petridou ET 

Collaborators 

Margarita Baka, Maria Moschovi, Sophia Polychronopoulou, Maria Kourti, Emmanuel Hatzipantelis, Iordanis Pelagiadis, Helen Dana, Maria Kantzanou, Marianna Tzanoudaki, Theodora Anastasiou, Maria Grenzelia, Eleni Gavriilaki, Ioanna Sakellari, Achilles Anagnostopoulos, Vassiliki Kitra, Anna Paisiou, Evdoxia Bouka, Atte Nikkilä, Olli Lohi 

Eur J Cancer 2020; 130:1-11 

Allogeneic Hematopoietic Cell Transplantation in Patients with Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change 

Gavriilaki E, Sakellari I, Mallouri D, Batsis I, Chatziconstantinou T, Vardi A, Bousiou Z, Masmanidou M, Douka V, Syrigou A, Sotiropoulos D, Constantinou V, Anagnostopoulos A 

HemaSphere 2020 Apr 1;4(2):e3452020 

Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics 

Gavriilaki M, Kimiskidis VK, Gavriilaki E 

Pharmaceuticals (Basel) 2020 Oct 26;13(11):341 

Platelet microvesicles are associated with the severity of coronary artery disease: comparison between peripheral and coronary circulation 

Gkaliagkousi E, Gavriilaki E, Yiannaki E, Vasileiadis I, Nikolaidou B, Lazaridis A, Dolgyras P, Grigoriadis S, Triantafyllou A, Anyfanti P, Markala D, Zarifis I, Douma S. J Thromb Thrombolysis. 2020 [ahead of print]. 

Δράσεις υδροξυουρίας – Έλεγχος ενεργοποίησης συμπληρώματος 

Γαβριηλάκη Ε, Βαρελάς Χ, Βλαχάκη Ε 

Haema 2020; 11(Suppl 1): 179-184 

Effect of the COVID-19 pandemic on laboratory and clinical research: a testimony and a call to action from researchers 

Kabanova Α, Gavriilaki Ε, Pelzer Β, Brunetti L, Maiques-Diaz A 

Hemasphere 2020 Nov 24;4(6):e499 

Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses 

Gavriilaki E, Anyfanti P, Gavriilaki M, Lazaridis A, Douma S, Gkaliagkousi E. 

Curr Hypertens Rep 2020 Aug 27;22(9):63 

Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily 

Gavriilaki E, Brodsky RA 

Br J Haematol 2020;189(6): e227-e230 

Complementopathies and precision medicine 

Gavriilaki E, Brodsky RA 

J Clin Invest 2020; 30(5):2152-2163 

Endothelial Dysfunction in Patients with Rheumatoid Arthritis: The Role of Hypertension 

Anyfanti P, Gavriilaki E, Douma S, Gkaliagkousi E 

Curr Hypertens Rep 2020 Jul 15;22(8):56 

The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II 

Nikolaidou B, Gkaliagkousi E, Anyfanti P, Gavriilaki E, Lazaridis A, Triantafyllou A, Zografou I, Douma S 

BMC Nephrol 2020 Apr 6;21(1):119 

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE) 

Sharrack B., Saccardi R., Alexander T., Badoglio M., Burman J., Farge D., Greco R., Jessop H., Kazmi M., Kirgizov K., Labopin M., Mancardi G., Martin R., Moore J., Muraro P.A., Rovira M., Sormani M.P., Snowden J.A. European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE) 

Collaborators 

European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE): J Snowden, R Saccardi, E McGrath, F Bambi, F SanchezGuijo, N Worel, J Snowden, T Alexander, M Badolglio, M Abinun, R Arnold, C Brierley, J Burman, C CastillaLlorente, N Cooper, T Daikeler, N Del Papa, D Farge, J Finke, R Greco, H Hagglund, J Henes, F Hiepe, H Jessop, D Kiely, M Labopin, M Kazmi, K Kirgizov, G Mancardi, Z Marjanovic, R Martin, T Martin, D Ma, J Moore, P Miller, P Muraro, M-C Oliveira, A Polushin, F Onida, B Simoes, M Puyade, I Resnick, M Rovira, R Saccardi, M Saif, I Sakellari, B Sharrack, E Snarski, H U Scherer, C Sossa, J de Vries-Bouwstra, N Wulffraat, E Zaccara 

Bone Marrow Transplant 2020 Feb;55(2):283-306 

High-throughput analysis of the T cell receptor gene repertoire in low-count monoclonal B cell lymphocytosis reveals a distinct profile from chronic lymphocytic leukemia 

Agathangelidis, C. Galigalidou, L. Scarfò, T. Moysiadis, A. Rovida, E. Vlachonikola, E. Sofou, F. Psomopoulos, A. Vardi, P. Ranghetti, A. Siorenta, A 

Galanis, K. Stamatopoulos, A. Chatzidimitriou, P. Ghia 

Haematologica 2020 Oct 1;105(10):e515

Δημοσιεύσεις εργασιών 2019

Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality 

Sakellari I, Gavriilaki E, Papagiannopoulos S, Gavriilaki M, Batsis I, Mallouri D, Vardi A, Constantinou V, Masmanidou M, Yannaki E, Smias C, Geroukis T, Kazis D, Kimiskidis V, Anagnostopoulos A 

J Neurol 2019;266(8):1960-1972 

Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system 

Diamantopoulos PT, Kotsianidis I, Symeonidis A, Pappa V, Galanopoulos A, Gogos D, Karakatsanis S, Papadaki H, Palla A, Hatzimichael E, Dimou M, Papageorgiou S, Delimpasis S, Papaioannou M, Papoutselis M, Kourakli A, Tsokanas D, Anagnostopoulos A, Kontos CK, Panayiotidis P, Viniou NA; Hellenic MDS study group 

Leuk Lymphoma 2019 Jul;60(7):1721-1730 

Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment 

Demosthenous C, Lalayanni C, Iskas M, Douka V, Pastelli N, Anagnostopoulos A. Curr Probl Cancer 2019 Jun;43(3):222-227 

Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors 

Moysiadis T, Baliakas P, Rossi D, Catherwood M, Strefford JC, Delgado J, Anagnostopoulos A, Belessi C, Stavroyianni N, Pospisilova S, Oscier D, Gaidano G, Campo E, Rosenquist R, Ghia P, Stamatopoulos K 

Leukemia. 2019 Jul;33(7):1801-1805 

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations and clinical impact 

Baliakas P, Jeromin S, Iskas M, Puiggros A, Plevova K, NguyenKhac F, Davis Z, Rigolin GM, Visentin A, Xochelli A, Delgado J, Baran-Marszak F, Stalika E,Abrisqueta P, Durechova K, Papaioannou G, Eclache V, Dimou M, Iliakis T, Collado R, Doubek M, Calasanz MJ, Ruiz-Xiville N, Moreno C, Jarosova M, Leeksma AC,Panayiotidis P, Podgornik H, Cymbalista F, Anagnostopoulos A, Trentin L, Stavroyianni N, Davi F, Ghia P, Kater AP, Cuneo A, Pospisilova S, Espinet B, Athanasiadou A, Oscier D, Haferlach C, Stamatopoulos K 

Blood 2019 Mar 14;133(11):1205-1216 

Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations 

Xochelli A, Bikos V, Polychronidou E, Galigalidou C, Agathangelidis A,Charlotte F, Moschonas P, Davis Z, Colombo M, Roumelioti M, Sutton LA, Groenen P,van den Brand M, Boudjoghra M, Algara P, Traverse-Glehen A, Ferrer A, Stalika E, Karypidou M, Kanellis G, Kalpadakis C, Mollejo M, Pangalis G, Vlamos P, Amini RM,Pospisilova S, Gonzalez D, Ponzoni M, Anagnostopoulos A, Giudicelli V, Lefranc MP, Espinet B, Panagiotidis P, Piris MA, Du MQ, Rosenquist R, Papadaki T, Belessi C, Ferrarini M, Oscier D, Tzovaras D, Ghia P, Davi F, Hadzidimitriou A, K Stamatopoulos 

J Pathol 2019 Apr;247(4):416-421 

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia 

Baliakas P, Moysiadis T, Hadzidimitriou A, Xochelli A, Jeromin S, Agathangelidis A, Mattsson M, Sutton LA, Minga E, Scarfò L, Rossi D, Davis Z,V illamor N, Parker H, Kotaskova J, Stalika E, Plevova K, Mansouri L, Cortese D,Navarro A, Delgado J, Larrayoz M, Young E, Anagnostopoulos A, Smedby KE, Juliusson G, Sheehy O, Catherwood M, Strefford JC, Stavroyianni N, Belessi C, Pospisilova S, Oscier D, Gaidano G, Campo E, Haferlach C, Ghia P, Rosenquist R, K. Stamatopoulos 

Haematologica 2019 Feb;104(2):360-369 

Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath? 

Papalexandri A, Karypidou M, Stalika E, Kotta K, Touloumenidou T, Zerva P, Paleta A, Mallouri D, Batsis I, Sakellari I, Kotsianidis I, Anagnostopoulos A, Hadzidimitriou A, Margaritis D, Stamatopoulos K 

Leuk Lymphoma 2019 Jul;60(7):1685-1692 

In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia 

Wang H, Georgakopoulou A, Psatha N, Li C, Capsali C, Samal HB, Anagnostopoulos A, Ehrhardt A, Izsvák Z, Papayannopoulou T, Yannaki E, A. Lieber 

J Clin Invest 2019 Feb 1;129(2):598-615 

Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis 

Anyfanti P, Gkaliagkousi E, Gavriilaki E, Triantafyllou A, Dolgyras P, Galanopoulou V, Aslanidis S, Douma S 

Clin Cardiol. 2019 Jan;42(1):62-68 

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) by real-time quantitative PCR of p190 BCR-ABL 

Pfeifer H., Cazzaniga G., Van der Velden VHJ, Cayuela, JM., Schaefer, B., Spinelli, O., Akiki, S. Avigad, S., Bendit, I., Borg, K., Cave, H., Elia, L., CastierFoster, J., Gerrard,G., Hayette, S., Herrmansson, M., Juh, A., Jurcek, T., Chillon, MC., Homburg, C., Martinelli, G., Kairisto, V., Lange, T., Lion, T., Mueller, MC., Pane, F., Rai, L., Roettgers, S., Sacha, T., Schnittger, S., Touloumenidou, T., Valerhaugen, H., Van den Berghe, P., Zuna, J., Serve, H., Herrmann, E., Marcovic, S., van Dongen JJM, and Ottmann OG 

Leukemia 2019 Aug;33(8):1910-1922 

BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma 

Sakellari I, Gavriilaki E, Bouziana S, Constantinou V, Mallouri D, Vardi A, Marvaki A, Batsis I, Sotiropoulos D, Anagnostopoulos A 

Bone Marrow Transplant2019 Jun;54(6):921-923 

Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease 

Gavriilaki E, Sakellari I, Karafoulidou I, Pasteli N, Batsis I, Mallouri D, Lazaridou A, Iskas M, Vardi A, Papalexandri A, Tsompanakou A, Papaemmanouil S, Ilias A, Anagnostopoulos A 

Int J Hematol 2019 Nov;110(5):529-532 

Neurologic complications after allogeneic transplantation: a meta-analysis 

Gavriilaki M, Mainou M, Gavriilaki E, Haidich AB, Papagiannopoulos S, Sakellari I, Anagnostopoulos A, Kimiskidis V 

Ann Clin Transl Neurol 2019 Oct;6(10):2037-2047 

Early Prediction of Cardiovascular Risk after Hematopoietic Cell Transplantation: Are We There Yet? 

Gavriilaki E, Gkaliagkousi E, Sakellari I, Anyfanti P, Douma S, Anagnostopoulos A 

Biol Blood Marrow Transplant 2019 Oct;25(10): e310-e316 

Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic Microangiopathy 

Gavriilaki E, Chrysanthopoulou A, Sakellari I, Batsis I, Mallouri D, Touloumenidou T, Papalexandri A, Mitsios A, Arampatzioglou A, Ritis K, Brodsky RA, Mitroulis I, Anagnostopoulos A 

Thromb Haemost 2019 Sep;119(9):1433-1440 

Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia 

Sakellari I, Gavriilaki E, Batsis I, Mallouri D, Gavriilaki M, Apostolou C, Iskas M, Voutiadou G, Bouziana S, Bousiou Z, Constantinou V, Masmanidou M, Sotiropoulos D, Yannaki E, Lalayanni C, Pilavaki M, Chatziioannou K, Papayannopoulos S, Anagnostopoulos A 

Biol Blood Marrow Transplant 2019 Sep;25(9):1756-1760 

Hypertension in hematologic malignancies and hematopoietic cell transplantation: An emerging issue with the introduction of novel treatments 

Gavriilaki E, Gkaliagkousi E, Grigoriadis S, Anyfanti P, Douma S, Anagnostopoulos A 

Blood Rev. 2019;35:51-58 

Complement in Thrombotic Microangiopathies: Unraveling Ariadne’s Thread into the Labyrinth of Complement Therapeutics 

Gavriilaki E, Anagnostopoulos A, Mastellos DC 

Front Immunol. 2019;10:337 

Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents 

Gavriilaki M, Sakellari I, Gavriilaki E, Kimiskidis VK, Anagnostopoulos A 

Stem Cells Int 2019 Jun 24;2019:5840286 

Brentuximab vedotin and anti-PD1 treatment optimize survival in chemorefractory Hodgkin lymphoma patients: Real-world data 

Sakellari I, Gavriilaki E, Iskas M, Bousiou Z, Chatziioannidis A, Batsis I, Mallouri D, Constantinou V, Stavroyianni N, Syrigou A, Marvaki A, Pilavaki M, Papaemmanouil S, Anagnostopoulos A 

Hematol Oncol 2019 Oct;37(4):490-492 

Hepatic Extramedullary Plasmacytomas Post Tandem Haematopoietic Transplantation for Multiple Myeloma: A Therapeutic Challenge 

Sakellari Ι, Batsis Ι, Mallouri D, Lalayanni C, Gavriilaki E, Karampekou V, Palladas P, Matzarakis I, Smias C, Anagnostopoulos A 

Haema 2019; 10(1):46-49 

DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy 

Tsagiopoulou, N. Papakonstantinou, T. Moysiadis, L. Mansouri, V. Ljungström, M. Duran-Ferrer, A. Malousi, AC. Queirós, K. Plevova, S. Bhoi, P. Kollia, D. Oscier, A. Anagnostopoulos, L. Trentin, M. Ritgen, S. Pospisilova, N. Stavroyianni, P. Ghia, JI. Martin-Subero, C. Pott, R. Rosenquist, K. Stamatopoulos 

Clin Epigenetics 2019 Dec 2;11(1):177 

Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia 

Chartomatsidou, S. Ntoufa, K. Kotta, A. Rovida, MA. Akritidou, D. Belloni, E. Ferrero, T. Trangas, N. Stavroyianni, A. Anagnostopoulos, R. Rosenquist, P. Ghia, N. Papakonstantinou, K. Stamatopoulos 

Blood Adv 2019 Jun 25;3(12):1891-1896 

Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors 

T. Moysiadis, P. Baliakas, D. Rossi, M. Catherwood, JC. Strefford, J. Delgado, A. Anagnostopoulos, C.  Belessi, N. Stavroyianni, S. Pospisilova, D. Oscier, G. Gaidano, E. Campo, R. Rosenquist, P. Ghia, K. Stamatopoulos 

Leukemia. 2019 Jul;33(7):1801-1805 

Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host 

Papadopoulou A, Alvanou M, Koukoulias K, Athanasiou E, Lazaridou A, Savvopoulos N, Kaloyannidis P, Markantonatou AM, Vyzantiadis TA, Yiangou M, Anagnostopoulos A, Yannaki E 

Bone Marrow Transplant2019 Dec;54(12):2120 

Identification of miRNAs from stem cell derived microparticles in umbilical cord blood 

Xagorari A, Gerousi M, Sioga A, Bougiouklis D, Argiriou A, Anagnostopoulos A, Sotiropoulos D 

Exp Hematol 2019 Dec;80:21-26 

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation 

Cremers EMP, de Witte T, de Wreede L, Eikema DJ, Koster L, van Biezen A, Finke J, Socié G, Beelen D, Maertens J, Nagler A, Kobbe G, Ziagkos D, Itälä-Remes M, Gedde-Dahl T, Sierra J, Niederwieser D, Ljungman P, Beguin Y, Ozkurt ZN, Anagnostopoulos A, Jindra P, Robin M, Kröger N 

Leuk Lymphoma 2019 Oct;60(10):2404-2414 

Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE- HSCT) 

Curran D, Matthews S, Rowley SD, Young JH, Bastidas A, Anagnostopoulos A, Barista I, Chandrasekar PH, Dickinson M, El Idrissi M, Heras I, Milliken ST, Monserrat Coll J, Navarro Matilla MB, Oostvogels L, Piątkowska-Jakubas B, Quiel D, Sabry W, Schwartz S, Selleslag DLD, Sullivan KM, Theunissen K, Yegin ZA, Yeh SP, Zaja F, Szer J; ZOE-HSCT Study group collaborators 

Biol Blood Marrow Transplant 2019. Dec;25(12):2474-2481 

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial 

Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, López-Jiménez J, Vural F, Pohlreich D, Zuckerman T, Issa NC, Gaidano G, Lee JJ, Abhyankar S, Solano C, Perez de Oteyza J, Satlin MJ, Schwartz S, Campins M, Rocci A, Vallejo Llamas C, Lee DG, Tan SM, Johnston AM, Grigg A, Boeckh MJ, Campora L, Lopez-Fauqued M, Heineman TC, Stadtmauer EA, Sullivan KM; ZOE-HSCT Study Group Collaborators 

JAMA 2019 Jul 9;322 (2):123-133 

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial 

Mullane KM, Morrison VA, Camacho LH, Arvin A, McNeil SA, Durrand J, Campbell B, Su SC, Chan ISF, Parrino J, Kaplan SS, Popmihajlov Z, Annunziato PW; V212 Protocol 011 Trial Team 

Lancet Infect Dis. 2019 Sep;19(9):1001-1012 

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial 

Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O’Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators 

Lancet Oncol 2019 Jun;20(6):781-794 

Oral ixazomib maintenance following autologous stem cell transplantation  (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial 

Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group 

Lancet 2019 Jan 19;393(10168):253-264 

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study 

Attal M, Richardson PG, Rajkumar SV, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Macé S, Corzo KP, Campana F, Le-Guennec S, Dubin F, Anderson KC; ICARIA-MM study group 

Lancet 2019 Dec 7;394(10214):2096-2107 

Endothelial microvesicles circulating in peripheral and coronary circulation are associated with central blood pressure in coronary artery disease 

Gkaliagkousi E, Gavriilaki E, Vasileiadis I, Nikolaidou B, Yiannaki E, Lazaridis A, Triantafyllou A, Anyfanti P, Markala D, Zarifis I, Douma S 

Am J Hypertens 2019 Nov 15;32(12):1199-1205 

Increased erythrocyte- and platelet-derived microvesicles in newly diagnosed type 2 diabetes mellitus 

Gkaliagkousi E, Nikolaidou B, Gavriilaki E, Lazaridis A, Yiannaki E, Anyfanti P, Zografou I, Markala D, Douma S 

Diab Vasc Dis Res 2019;16(5):458-465 

High-Throughput Sequencing of the T-Cell Receptor Beta Chain Gene Repertoire in Chronic Lymphocytic Leukemia 

Vlachonikola E, Vardi A, Stamatopoulos K, Hadzidimitriou A 

Methods Mol Biol 2019; 1881:355-363 

Genetic history of the population of Crete 

Drineas P, Tsetsos F, Plantinga A, Lazaridis I, Yannaki E, Razou A, Kanaki K, Michalodimitrakis M, Perez-Jimenez F, De Silvestro G, Renda MC, Stamatoyannopoulos JA, Kidd KK, Browning BL, Paschou P, Stamatoyannopoulos G 

Ann Hum Genet. 2019 Nov;83(6):373-388 

Aspergillus galactomannan detection: Trichoderma as a cause of positive results 

Markantonatou AM, Samaras K, Yannaki E, Zachrou E, Vyzantiadis TA 

Curr Microbiol 2019 Jan;76(1):48-51 

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 

Pfeifer H, Cazzaniga G, van der Velden VHJ, Cayuela JM, Schäfer B, Spinelli O, Akiki S, Avigad S, Bendit I, Borg K, Cavé H, Elia L, Reshmi SC, Gerrard G, Hayette S, Hermanson M, Juh A, Jurcek T, Chillón MC, Homburg C, Martinelli G, Kairisto V, Lange T, Lion T, Mueller MC, Pane F, Rai L, Damm-Welk C, Sacha T, Schnittger S, Touloumenidou T, Valerhaugen H, Vandenberghe P, Zuna J, Serve H, Herrmann E, Markovic S, Dongen JJMV, Ottmann OG 

Leukemia 2019 Aug;33(8):1910-1922 

Dichotomous Toll-like receptor responses in chronic lymphocytic leukemia patients under ibrutinib treatment 

Gounari M, Ntoufa S, Gerousi M, Vilia MG, Moysiadis T, Kotta K, Papakonstantinou N, Scarfò L, Agathangelidis A, Fonte E, Ranghetti P, Nenou A, Xochelli A, Coscia M, Tedeschi A, Stavroyianni N, Muzio M, Stamatopoulos K, Ghia P 

Leukemia 2019 Apr;33(4):1030-1051 

EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia 

Kosalai ST, Morsy MHA, Papakonstantinou N, Mansouri L, Stavroyianni N, Kanduri C, Stamatopoulos K, Rosenquist R, Kanduri M 

Epigenetics. 2019 Nov;14(11):1125-1140 

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia 

Papakonstantinou N, Ntoufa S, Tsagiopoulou M, Moysiadis T, Bhoi S, Malousi A, Psomopoulos F, Mansouri L, Laidou S, Papazoglou D, Gounari M, Pasentsis K, Plevova K, Kuci-Emruli V, Duran-Ferrer M, Davis Z, Ek S, Rossi D, Gaidano G, Ritgen M, Oscier D, Stavroyianni N, Pospisilova S, Davi F, Ghia P, Hadzidimitriou A, Belessi C, Martin-Subero JI, Pott C, Rosenquist R, Stamatopoulos K 

Int J Cancer 2019 Jun 1;144(11):2695-2706 

Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors 

Li C, Mishra AS, Gil S, Wang M, Georgakopoulou A, Papayannopoulou T, Hawkins RD, Lieber A 

Mol Ther 2019 Aug 18;27(12):2195-2212 

Δημοσιεύσεις εργασιών 2018

BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma 

Sakellari I, Gavriilaki E, Bouziana S, Constantinou V, Mallouri D, Vardi A, Marvaki A, Batsis I, Sotiropoulos D, Anagnostopoulos A 

Bone Marrow Transplant 2018 Nov 8 

The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease 

N Zogas, G Karponi, F Iordanidis, S Malasidis, V Paraskevas, APapadopoulou, ZG Scouras, A Anagnostopoulos, E Yannaki 

Cytotherapy. 2018 Jan;20(1):149-164 

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience 

MK Angelopoulou, TP Vassilakopoulos, I Batsis, I Sakellari, K Gkirkas, V Pappa, P Giannoulia, I Apostolidis, C Apostolopoulos, P Roussou, P Panayiotidis, M Dimou, MC Kyrtsonis, M Palassopoulou, G Vassilopoulos, M Moschogiannis, C Kalpadakis, D Margaritis, A Spyridonidis, E Michalis, K Anargyrou, P Repousis, E Hatzimichael, Z Bousiou, E Poulakidas, D Grentzelias, N Harhalakis, GA Pangalis, A Anagnostopoulos, P Tsirigotis. 

Hematol Oncol 2018 Feb;36(1):174-181 

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy 

Baliakas P, Mattsson M, Hadzidimitriou A, Minga E, Agathangelidis A, Sutton LA, Scarfo L, Davis Z, Yan XJ, Plevova K, Sandberg Y, Vojdeman FJ, Tzenou T, Chu  CC, Veronese S, Mansouri L, Smedby KE, Giudicelli V, Nguyen-Khac F, Panagiotidis  P, Juliusson G, Anagnostopoulos A, Lefranc MP, Trentin L, Catherwood M, Montillo  M, Niemann CU, Langerak AW, Pospisilova S, Stavroyianni N, Chiorazzi N, Oscier D, Jelinek DF, Shanafelt T, Darzentas N, Belessi C, Davi F, Ghia P, Rosenquist R, Stamatopoulos K 

Haematologica. 2018 Apr;103(4):e158-e161 

Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis 

Tsirigotis P, Vassilakopoulos T, Batsis I, Bousiou Z, Gkirkas K, Sakellari I, Kaloyannidis P, Roussou P, Pangalis GA, Moschogiannis M, Vassilopoulos G, Repousis P, Megalakaki A, Michalis E, Kalpadakis C, Papadaki HA, Kotsianidis I, Hatzimichael E, Spyridonidis A, Anargyrou K, Poulakidas E, Giannoullia P, Apostolidis I, Stamouli M, Konstantopoulos K, Pappa V, Panayiotidis P, Harhalakis N, Anagnostopoulos A, Angelopoulou M 

Hematol Oncol 2018 Oct;36(4):645-650 

Reader response: Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke 

Gavriilaki M, Sakellari I, Kimiskidis V 

Neurology 2018 Nov 6;91(19):898-899 

Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation 

Gavriilaki E, Sakellari I, Batsis I, Mallouri D, Bousiou Z, Vardi A, Yannaki E, Constantinou V, Tsompanakou A, Vadikoliou C, Kaloyannidis P, Bamihas G, Anagnostopoulos A 

Clin Transplant 2018;32(9):e13371 

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study 

Sakellari I, Gavriilaki E, Batsis I, Mallouri D, Panteliadou AK, Lazaridou A, Vardi A, Constantinou V, Yannaki E, Papalexandri A, Kaloyannidis P, Smias C, Anagnostopoulos A 

Clin Apher 2018;33(6):654-660 

Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study 

Sakellari I, Gavriilaki E, Chatziioannou K, Papathanasiou M, Mallouri D, Batsis I, Bousiou Z, Bouziana S, Constantinou V, Douka V, Apostolou C, Iskas M, Lalayanni C, Athanasiadou A, Sotiropoulos D, Yannaki E, Gianouzakos V, Anagnostopoulos A 

Ann Hematol 2018;97(10):1987-1994 

Donor EBV at the time of hematopoietic cell transplantation: Is it time to adopt molecular assays? 

Sakellari I, Papalexandri A, Mallouri D, Batsis I, Iskas M, Xochelli A, Marvaki A, Gavriilaki E, Vardi A, Zerva P, Touloumenidou T, Anagnostopoulos A. J ClinVirol 2018; 21(102):32-33 

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia 

Gavriilaki E, Christodoulou I, Koravou EE, Paleta A, Koutra M, Zerva P, Touloumenidou T, Papalexandri A, Apostolou C, Klonizakis P, Anagnostopoulos A, Vlachaki E 

HemaSphere 2018 Oct;2(5):e58;1-3 

Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition 

Vlachaki E, Gavriilaki E, Kafantari K, Adamidou D, Tsitsikas D, Chasapopoulou E, Anagnostopoulos A, Tsapas A 

Hemoglobin 2018 Sep – Nov;42(5-6):339-341 

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival 

Katodritou E, Kyrtsonis MC, Delimpasi S, Kyriakou D, Symeonidis A, Spanoudakis E, Vasilopoulos G, Anagnostopoulos A, Kioumi A, Zikos P, Aktypi A, Briasoulis E, Megalakaki A, Repousis P, Adamopoulos I, Gogos D, Kotsopoulou M, Pappa V, Papadaki E, Fotiou D, Nikolaou E, Giannopoulou E, Hatzimichael E, Giannakoulas N, Douka V, Kokoviadou K, Timotheatou D, Terpos E 

Ann Hematol 2018 Sep;97(9):1671-1682 

A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS 

Fenaux P, Santini V, Spiriti MAA, Giagounidis A, Schlag R, Radinoff A, Gercheva-Kyuchukova L, Anagnostopoulos A, Oliva EN, Symeonidis A, Berger 

MH, Götze KS, Potamianou A, Haralampiev H, Wapenaar R, Milionis I, Platzbecker U 

Leukemia 2018 Dec;32(12):2648-2658 

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group 

Katodritou E, Terpos E, Delimpasi S, Kotsopoulou M, Michalis E, Vadikolia C, Kyrtsonis MC, Symeonidis A, Giannakoulas N, Vadikolia C, Michael M, Kalpadakis C, Gougopoulou T, Prokopiou C, Kaiafa G, Christoulas D, Gavriatopoulou M, Giannopoulou E, Labropoulou V, Verrou E, Kastritis E, Konstantinidou P, Anagnostopoulos A, Dimopoulos MA 

Blood Cancer J 2018 Mar 9;8(3):31 

Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment 

Kokoris SI, Gavriilaki E, Miari A, Travlou Α, Kyriakou E, Anagnostopoulos A, Grouzi E 

Hematology. 2018 Sep;23(8):558-566 

Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebocontrolled, phase 2 trial 

Mittelman M, Platzbecker U, Afanasyev B, Grosicki S, Wong RSM, Anagnostopoulos A, Brenner B, Denzlinger C, Rossi G, Nagler A, Garcia-Delgado R, Portella MSO, Zhu Z, Selleslag D 

Lancet Haematol 2018 Jan;5(1):e34-e43 

Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party 

Auner HW, Iacobelli S, Sbianchi G, Knol-Bout C, Blaise D, Russell NH, Apperley JF, Pohlreich D, Browne PV, Kobbe G, Isaksson C, Lenhoff S, Scheid C, Touzeau C, Jantunen E, Anagnostopoulos A, Yakoub-Agha I, Tanase A, Schaap N, Wiktor-Jedrzejczak W, Krejci M, Schönland SO, Morris C, Garderet L, Kröger N 

Haematologica 2018 Mar;103(3):514-521 

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy 

Baliakas P, Mattsson M, Hadzidimitriou A, Minga E, Agathangelidis A, Sutton LA, Scarfo L, Davis Z, Yan XJ, Plevova K, Sandberg Y, Vojdeman FJ, Tzenou T, Chu CC, Veronese S, Mansouri L, Smedby KE, Giudicelli V, Nguyen-Khac F, Panagiotidis P, Juliusson G, Anagnostopoulos A, Lefranc MP, Trentin L, Catherwood M, Montillo M, Niemann CU, Langerak AW, Pospisilova S, Stavroyianni N, Chiorazzi N, Oscier D,Jelinek DF, Shanafelt T, Darzentas N, Belessi C, Davi F, Ghia P, Rosenquist R,Stamatopoulos K 

Haematologica 2018 Apr;103(4):e158-e161 

Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop? 

Papalexandri A, Saloum R, Touloumenidou T, Papathanasiou M, Lalayanni C, Baldoumi E, Demosthenous C, Zerva P, Koutra MG, Athanasiadou A, Anagnostopoulos A 

HemaSphere 2018 2(6):e157 

The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease 

Zogas N, Karponi G, Iordanidis F, Malasidis S, Paraskevas V, Papadopoulou A, Scouras ZG, Anagnostopoulos A, Yannaki E 

Cytotherapy 2018 Jan;20(1):149-164 

The Functional Effect of Repeated Cryopreservation on Transduced CD34+ Cells from Patients with Thalassemia 

Karponi G, Papayanni PG, Zervou F, Bouinta A, Anagnostopoulos A, Yannaki E. Hum Gene Ther Methods 2018 Oct;29(5):220-227 

Ο ρόλος της μεταμόσχευσης μυελού των οστών στα Μυελοδυσπλαστικά Σύνδρομα 

Ε. Γαβριηλάκη, Ι. Σακελλάρη 

Haema 2018; 9 (Supp 1):34-36 

Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes 

Gkaliagkousi E, Gavriilaki E, Triantafyllou A, Nikolaidou B, Anyfanti P, Koletsos N, Vamvakis A, Dipla K, Lazaridis A, Douma S 

J Clin Hypertens (Greenwich) 2018 Apr;20(4):680-685 

Aldosterone as a mediator of microvascular and macrovascular damage in a population of normotensive to early-stage hypertensive individuals 

Gkaliagkousi E, Anyfanti P, Triantafyllou A, Gavriilaki E, Nikolaidou B, Lazaridis A, Vamvakis A, Douma S 

J Am Soc Hypertens 2018;12(1):50-57 

Exercise-induced benefits in metabolic syndrome 

Gkaliagkousi E, Gavriilaki E, Douma S 

J Clin Hypertens (Greenwich) 2018;20(1):19-21 

Aspergillus galactomannan detection: Trichoderma as a cause of positive results 

Markantonatou AM, Samaras K, Yannaki E, Zachrou E, Vyzantiadis TA. Curr Microbiol 2019 Jan;76(1):48-51 

Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major 

Psatha N, Reik A, Phelps S, Zhou Y, Dalas D, Yannaki E, Levasseur DN, Urnov FD, Holmes MC, Papayannopoulou T 

Mol Ther Methods Clin Dev. 2018 Aug 14;10:313-326 

A New Era for Hemoglobinopathies: More Than One Curative Option 

Psatha N, Papayanni PG, Yannaki E 

Curr Gene Ther 2018;17(5):364-378 

Alternative approaches to the therapeutic drug monitoring of prophylactic posaconazole in haematology patients 

Vyzantiadis TA, Yannaki E, Oliver DA, Markantonatou AM, Boussiou Z, Louka A, Zachrou E, Johnson EM 

J Mycol Med 2018 Mar;28(1):65-69 

Μinimal Information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines 

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, Borràs FE, Bosch S, Boulanger CM, Breakefield X, Breglio AM, Brennan MÁ, Brigstock DR, Brisson A, Broekman ML, Bromberg JF, Bryl-Górecka P, Buch S, Buck AH, Burger D, Busatto S, Buschmann D, Bussolati B, Buzás EI, Byrd JB, Camussi G, Carter DR, Caruso S, Chamley LW, Chang YT, Chen C, Chen S, Cheng L, Chin AR, Clayton A, Clerici SP, Cocks A, Cocucci E, Coffey RJ, Cordeiro-da-Silva A, BW, Soekmadji C, Sotillo J, Stahl PD, Stoorvogel W, Stott SL, Strasser EF, Swift S, Tahara H, Tewari M, Timms K, Tiwari S, Tixeira R, Tkach M, Toh WS, Tomasini R, Torrecilhas AC, Tosar JP, Toxavidis V, Urbanelli L, Vader P, van Balkom BW, van der Grein SG, Van Deun J, van Herwijnen MJ, Van KeurenJensen K, van Niel G, van Royen ME, van Wijnen AJ, Vasconcelos MH, Vechetti IJ Jr, Veit TD, Vella LJ, Velot É, Verweij FJ, Vestad B, Viñas JL, Visnovitz T, Vukman KV, Wahlgren J, Watson DC, Wauben MH, Weaver A, Webber JP, Weber V, Wehman AM, Weiss DJ, Welsh JA, Wendt S, Wheelock AM, Wiener Z, Witte L, Wolfram J, Xagorari A, Xander P, Xu J, Yan X, Yáñez-Mó M, Yin H, Yuana Y, Zappulli V, Zarubova J, Žėkas V, Zhang JY, Zhao Z, Zheng L, Zheutlin AR, Zickler AM, Zimmermann P, Zivkovic AM, Zocco D, Zuba-Surma EK 

J Extracell Vesicles 2018 Nov 23;7(1):1535750 

Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL 

G Blanco, A Vardi, A Puiggros, A Gomez-Llonin, M Nuro, M Rodriquez-Rivera, E Stalika, E Abella, E Gimeno, M Lopez-Sanchez, A senin, X Calvo, P Abrisqueta, F Bosch, A Ferrer, K Stamatopoulos, B Espinet 

Oncoimmunology 2018; 7(6):e1432328 

Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia 

E Polychronidou, I kalamaras, A Agathangelidis, LA Sutton, XJ Yan, V Bikos, A Vardi, K Mochament, N Chiorazzi, C Belessi, R Rosenquist, P Ghia, K Stamatopoulos, P Vlamos, A Chailyan, N Overby, P Marcatili, A Hatzidimitriou, D Tzovaras 

BMC Bioinformatics 2018; 19 (Suppl 14):414 

IRProfiler – a software toolbox for high-throughput immune receptor profiling 

C Maramis, A Gkoufas, A Vardi, E Stalika, K Stamatopoulos, A Hadzidimitriou, N Maglaveras, I Chouvarda 

BMC Bioinformatics 2018; 19(1):144 

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia 

Papakonstantinou N, Ntoufa S, Tsagiopoulou M, Moysiadis T, Bhoi S, Malousi A, Psomopoulos F, Mansouri L, Laidou S, Papazoglou D, Gounari M, Pasentsis K, Plevova K, Kuci-Emruli, Duran-Ferrer M, Davis Z, Ek S, Rossi D, Gaidano G, Ritgen M, Oscier D, Stavroyianni N, Pospisilova S, Davi F, Ghia P, Hadzidimitriou A, Belessi C, Martin-Subero JI, Pott C, Rosenquist R, Stamatopoulos K 

Int J Cancer. 2018 Nov 16. doi: 10.1002/ijc.31999

Δημοσιεύσεις εργασιών 2017

Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation 

Sakellari I, Mallouri D, Gavriilaki E, Batsis I, Kaliou M, Constantinou V, Papalexandri A, Lalayanni C, Vadikolia C, Athanasiadou A, Yannaki E, Sotiropoulos D, Smias C, Anagnostopoulos A 

Biol Blood Marrow Transplant. 2017;23(3):445-451 

Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with beta-thalassemia major 

V. Constantinou, A. Bouinta, G. Karponi, F. Zervou, P.G. Papayanni, G. Stamatoyannopoulos, A. Anagnostopoulos, Ε. Yannaki 

Transfusion. 2017 Apr;57(4):1031-1039 

Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases 

Sakellari, E. Gavriilaki, Z. Boussiou, I. Batsis, D. Mallouri, V. Constantinou, K. Kaloyannidis, E. Yannaki,G. Bamihas, A. Anagnostopoulos 

Hematol Oncol. 2017 Dec;35(4):932-934 

TP 53 Gene P72R polymorphism in Chronic Lymphocitic Leukemia: Incidence and clinical significance amongst cases with unmutated immunoglobulin receptors 

Gemenetzi, C. Galigalidou, E. Vlachonikola, E. Stalika, A. Xochelli, P. Baliakas, M. Karypidou, T. Touloumenidou, E. Minga, V. Douka, M. Iskas, A. Athanasiadou, A. Makris, N. Stavroyianni, A. Anagnostopoulos, A. Hadzidimitriou, K. Stamatopoulos 

Leuk Lymphoma. 2017 Mar;58(3):726-728 

Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: highthroughput immunoprofiling supports selection by shared antigenic elements 

A Vardi, E Vlachonikola, M Karypidou, E Stalika, V Bikos, K Gemenetzi, C Maramis, A Siorenta, A Anagnostopoulos, S Pospisilova, N Maglaveras, I Chouvarda, K Stamatopoulos, A Hadzidimitriou 

Leukemia 2017 Jul;31(7):1555-1561 

A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece 

Pappa V, Anagnostopoulos A, Bouronikou E, Briasoulis E, Kotsianidis I, Pagoni M, Zikos P, Tsionos K, Viniou N, Meletis J, Papadaki H, Kioumi A, Galanopoulos A, Vervessou EC, Poulakidas E, Karmas P, Karvounis K, Symeonidis A 

Int J Hematol. 2017 Feb;105(2):184-195 

Small-molecule Factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome 

Χ Yuan, Ε Gavriilaki, JA Thanassi, G Yang, AC Baines, SD Podos, Y Huang, M Huang, RA Brodsky 

Haematologica. 2017 Mar;102(3):466-475 

GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data 

Pal, Bystry V., Reigl T., Demko M., Krejci A, Touloumenidou T., Stalika E, 

Ghia P, Stamatopoulos K, Pospisilova S., Malcikova J, Darzentas N 

Bioinformatics 2017 Dec 1;33(23):3802-3804 

Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT 

Pavlů J, Labopin M, Zoellner AK, Sakellari I, Stelljes M, Finke J, Fanin R, Stuhler G, Afanasyev BV, Bloor AJ, Anagnostopoulos A, Mohty M, Giebel S, Nagler A 

Cancer. 2017 Jun 1;123(11):1965-1970 

In vitro evidence of complement activation in patients with sickle cell disease 

Gavriilaki E, Mainou M, Christodoulou I, Koravou EE, Paleta A, Touloumenidou T, Papalexandri A, Athanasiadou A, Apostolou C, Klonizakis P, Anagnostopoulos A, Vlachaki E 

Haematologica 2017 ;102(12): e481-e482 

Unraveling the Genetics of Transplant-Associated Thrombotic Microangiopathy: Lessons to be Learned 

Gavriilaki E, Sakellari I, Mallouri D, Batsis I, Yannaki E, Anagnostopoulos A 

BiolBloodMarrowTransplant 2017;23(11):2013-2014 

Transplant-associated thrombotic microangiopathy: opening Pandora’s box 

Gavriilaki E, Sakellari I, Anagnostopoulos A, Brodsky RA 

Bone Marrow Transplant 2017;52(10):1355-156 

The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies 

Sakellari I, Batsis I, Bousiou Z, Mallouri D, Constantinou V, Gavriilaki E, Smias C, Yannaki E, Kaloyannidis P, Papaioannou G, Stavroyianni N, Syrigou A, Sotiropoulos D, Fylaktou A, Tsompanakou A, Saloum R, Anagnostopoulos A 

Clin Lymphoma Myeloma Leuk 2017 Oct;17(10):658-666 

Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia 

Cornely OA, Leguay T, Maertens J, Vehreschild MJGT, Anagnostopoulos A, Castagnola C, Verga L, Rieger C, Kondakci M, Härter G, Duarte RF, Allione B, Cordonnier C, Heussel CP, Morrissey CO, Agrawal SG, Donnelly JP, Bresnik M, Hawkins MJ, Garner W, Gökbuget N; AmBiGuard Study Group 

J Antimicrob Chemother 2017 Aug 1;72(8):2359-2367 

Candida is an emerging pathogen beyond the neutropenic period of allogeneic hematopoietic cell transplantation 

Sakellari I, Gavriilaki E, Kaliou M, Mallouri D, Batsis I, Yannaki E, Smias C, Sotiropoulos D, Tsorlini E, Anagnostopoulos A 

Clin Transplant 2017;31(4) 

Numerous Ontogenetic Roads to Mantle Cell Lymphoma: Immunogenetic and Immunohistochemical Evidence 

E Pouliou, A Xochelli, G Kanellis, E Stalika, LA Sutton, A Navarro, A Agathangelidis, K Dimosthenous, A Anagnostopoulos, E Patsouris, P Korkolopoulou, C Sundstrom, P Ghia, M Ponzoni, B Sander, E Campo, R Rosenquist, A Hadzidimitriou, K Stamatopoulos, T Papadaki 

Am J Pathol. 2017 Jul;187(7):1454-1458 

Nelarabine-associated reversible Guillain-Barré-like syndrome or myelopathy in an adult patient with primary refractory T-lymphoblastic lymphoma 

Lalayanni C, Baldoumi E, Papayiannopoulos S, Tziola K, Saloum R, Anagnostopoulos A. 

Curr Probl Cancer 41 (2017) 138–143 

Genetics of the peloponnesean populations and the theory of extinction of the medieval peloponnesean Greeks 

G Stamatoyannopoulos, A Bose, A Teodosiadis, F Tsetsos, A Plantinga, N Psatha, N Zogas, E Yannaki, P Zalloua, KK Kidd, BL Browning, J Stamatoyannopoulos, P Paschou, P Drineas 

Eur J Hum Genet 2017 May;25(5):637-645 

A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model 

Yuan X, Li Z, Baines AC, Gavriilaki E, Ye Z, Wen Z, Braunstein EM, Biesecker LG, Cheng L, Dong X, Brodsky RA 

PLoS One 2017;12(4): e0174074 

In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy 

Rotz SJ, Luebbering N, Dixon BP, Gavriilaki E, Brodsky RA, Dandoy CE, Jodele S, Davies SM 

Blood Advances 2017;1(20), 1632-1634 

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes 

Xochelli A, Baliakas P, Kavakiotis I, Agathangelidis A, Sutton LA, Minga E, Ntoufa S, Tausch E, Yan XJ, Shanafelt T, Plevova K, Boudjogra M, Rossi D, Davis Z, Navarro A, Sandberg Y, Vojdeman FJ, Scarfo L, Stavroyianni N, Sudarikov A, Veronese S, Tzenou T, Karan-Djurasevic T, Catherwood M, Kienle D, Chatzouli M, Facco M, Bahlo J, Pott C, Pedersen LB, Mansouri L, Smedby KE, Chu CC, Giudicelli  V, Lefranc MP, Panagiotidis P, Juliusson G, Anagnostopoulos A, Vlahavas I, Antic  D, Trentin L, Montillo M, Niemann C, Döhner H, Langerak AW, Pospisilova S, Hallek M, Campo E, Chiorazzi N, Maglaveras N, Oscier D, Gaidano G, Jelinek DF, Stilgenbauer S, Chouvarda I, Darzentas N, Belessi C, Davi F, Hadzidimitriou A, Rosenquist R, Ghia P, Stamatopoulos K 

Clin Cancer Res 2017 Sep 1;23(17):5292-5301 

T cells in chronic lymphocytic leukemia: can they fight? 

Vardi, K. Stamatopoulos, A. Hadzidimitriou 

Oncotarget 2017 Nov;8(59):99209-99210 

Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Uganda population: a cross-sectional study 

AC. Rawstron, A. Ssemaganda, R. de Tute, C. Doughty, D. Newton, A. Vardi, PAS. Evans, K. Stamatopoulos, RG. Owen, T. Lightfoot, K. Wakeham, A. Karabarinde, G. Asiki, R. Newton 

Lancet Haemato. 2017 Jul;4(7): e334-40 

Cytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors 

S. Mastrodemou, E. Stalika, A. Vardi, K. Gemenetzi, M. Spanoudakis, M. Karypidou, I. Mavroudi, A. Hadzidimitriou, C. Stavropoulos-Giokas, HA. Papadaki, K. Stamatopoulos 

Leuk Lymphoma 2017 Dec;58(12):2926-33 

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation 

Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, Carrum G, Sasa G, Lulla P, Watanabe A, Kuvalekar M, Gee AP, Wu MF, Liu H, Grilley BJ, Krance RA, Gottschalk S, Brenner MK, Rooney CM, Heslop HE, Leen AM, Omer B 

J Clin Oncol 2017 Nov 1;35(31):3547-3557 

Primary Central Nervous System Lymphoma (PCNSL) and other rare primary extranodal lymphomas 

Lalagianni 

Haema 2017; 8(1): 64-73 

Haematopoietic cell transplantation (ΗCΤ) for Non-Hodgkin Lymphomas 

Sakellari 

Haema 2017; 8(1): 83-94 

Aggressive B-cell lymphomas: Prospects in the era of targeted therapy 

Vardi, M. Iskas, N. Stavrogianni 

Haema 2017; 8(1): 109-116

Δημοσιεύσεις εργασιών 2016

A Tribute to George Stamatoyannopoulos 

Srivastava A, Kay MA, Athanasopoulos T, Angastiniotis M, Anagnostopoulos A, Karponi G, Yannaki E, Zon LI, Lederer CW, Phylactides MS, Kleanthous M. Hum Gene Ther 2016 Apr;27(4):280-6 

Antigen Selection Shapes the T-cell Repertoire in Chronic Lymphocytic Leukemia 

Vardi, A. Agathangelidis, E. Stalika, M. Karypidou, A. Siorenta, A. Anagnostopoulos, R. Rosenquist, A. Hadzidimitriou, P. Ghia, LA Sutton, K. Stamatopoulos 

Clin Cancer Res 2016 Jan 1;22(1):167-74 

An immunogenetic signature of ongoing antigen interactions in Splenic Marginal Zone lymphoma expressing IGHV1-2*04 receptors 

V. Bikos, M. Karypidou, E. Stalika, P. Baliakas, A. Xochelli, LA. Sutton, G. Papadopoulos, A. Agathangelidis, E. Papadopoulou, Z. Davis, P. Algara, G. Kanellis, A. Traverse-Glehen, M. Mollejo, A. Anagnostopoulos, M. Ponzoni, D. Gonzalez, S. Pospisilova, E. Matutes, MA. Piris, T. Papadaki, P. Ghia, R. Rosenquist, D. Oscier, N. Darzentas, D. Tzovaras, C. Belessi, A. Hadzidimitriou, K. Stamatopoulos 

Clin Cancer Res 2016 Apr 15;22(8):2032-40 

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? 

MC. Oliveira, M. Labopin, J. Henes, J. Moore, ND. Papa, A. Cras, I. Sakellari, R. Schroers, HU. Scherer, A. Cuneo, S. Kyrcz-Krzemien, T. Daikeler, T. Alexander, J. Finke, M. Badoglio, B. Simões, JA. Snowden, D. Farge 

Bone Marrow Transplant 2016 Apr;51(4):501-5 

Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges 

Papadopoulou, P. Kaloyannidis, E. Yannaki, CR Cruz 

Crit Rev Oncol Hematol 2016 Feb;98:62-72 

Endogenous Neurogenesis, Histological and Behavioral Monitoring of Recovery of Paraplegia, after Total Spinal Cord Transection in Mice 

E. Athanasiou, D. Sotiropoulos, E. Siotou, K. Violaris, M. Bobos, A. Fassas, A. Anagnostopoulos 

MOJ Orthop Rheumatol 2016, 6(1): 00207 

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations 

Blanco, A. Puiggros, P. Baliakas, A. Athanasiadou, M. García-Malo, R. Collado, A. Xochelli, M. Rodríguez-Rivera, M Ortega, MJ Calasanz, E Luño, M. Vargas, J Grau, C Martínez-Laperche, A Valiente, J Cervera, A Anagnostopoulos, E Gimeno, E Abella, E Stalika, JM Hernández-Rivas, FJ Ortuño, D Robles, A Ferrer, D Ivars, M González, F Bosch, P Abrisqueta, K Stamatopoulos, B Espinet 

Oncotarget 2016 Dec 6;7(49):80916-80924 

The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia 

N Papakonstantinou, S Ntoufa, E Chartomatsidou, K Kotta, A Agathangelidis, L Giassafaki, T Karamanli, P Bele, T Moysiadis, P Baliakas, LA Sutton, N Stavroyianni, A Anagnostopoulos, AM Makris, P Ghia, R Rosenquist, K Stamatopoulos 

Oncotarget 2016 Jun 14;7(24):35946-35959 

Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference 

P Baliakas, A Puiggros, A Xochelli, LA Sutton, F Nguyen-Khac, A Gardiner, K Plevova, E Minga, A Hadzidimitriou, R Walewska, H McCarthy, M Ortega, R Collado, T González, I Granada, E Luño, J Kotašková, T Moysiadis, Z Davis, N Stavroyianni, A Anagnostopoulos, JC Strefford, S Pospisilova, F Davi, Athanasiadou, R Rosenquist, D Oscier, B Espinet, K Stamatopoulos 

Haematologica. 2016 Jul;101(7):e299-302 

B Cell Anergy Modulated by TLR1/2 and the miR-1792 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4 

S Ntoufa, N Papakonstantinou, B Apollonio, M Gounari, C Galigalidou, E Fonte, A Anagnostopoulos, C Belessi, M Muzio, P Ghia, K Stamatopoulos 

J Immunol 2016 May 15;196(10):4410-7 

An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors 

V Bikos, M Karypidou, E Stalika, P Baliakas, A Xochelli, LASutton, G Papadopoulos, A Agathangelidis, E Papadopoulou, Z Davis, P Algara, G Kanellis, A. Traverse-Glehen, M Mollejo, A Anagnostopoulos, M Ponzoni, D Gonzalez, S PospisilovA, E Matutes, MA Piris, T Papadaki, P Ghia, R Rosenquist, D Oscier, N Darzentas, D Tzovaras, C Belessi, A Hadzidimitriou, K Stamatopoulos 

Clin Cancer Res. 2016 Apr 15;22(8):2032-40 

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study 

Chanan-Khan A, Cramer P, Demirkan F, Fraser G, Silva RS, Grosicki S, Pristupa A, Janssens A, Mayer J, Bartlett NL, Dilhuydy MS, Pylypenko H, Loscertales J, Avigdor A, Rule S, Villa D, Samoilova O, Panagiotidis P, Goy A, Mato A, Pavlovsky MA, Karlsson C, Mahler M, Salman M, Sun S, Phelps C, Balasubramanian S, Howes A, Hallek M; HELIOS investigators (A. Anagnostopoulos) 

Lancet Oncol 2016 Feb;17(2):200-211 

Optimizing autologous cell grafts to improve stem cell gene therapy 

N. Psatha, G. Karponi, E. Yannaki 

Exp Hematol. 2016 Jul;44(7):528-39 

Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges 

Papadopoulou, P. Kaloyannidis, E. Yannaki,C.R.Cruz 

Crit Rev Oncol Hematol. 2016 Feb;98:62-72 

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres 

V Navrkalova, E. Young, P. Baliakas, L. Radova, LA Sutton, K. Plevova, L. Mansouri, V. Ljungström, S. Ntoufa, Z. Davis, G. Juliusson, KE Smedby, C. Belessi, P. Panagiotidis, T. Touloumenidou, F. Davi, AW Langerak, P. Ghia, JC Strefford, D. Oscier, J. Mayer, K. Stamatopoulos, S. Pospisilova, R. Rosenquist, M. Trbusek 

Haematologica 2016 Sep;101(9):e369-73 

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale 

NCP Cross, HE White, T. Ernst, L Welden, C Dietz, G Saglio, F-X Mahon, C Wong, D. Zheng, S Wong, S-S Wang, S Akiki, F Albano, J Anwar, H Andrikovics, G Balatzenco, I Bendit, J Beveridge, N Boeckx, N Cerveira, S Cheng, D Colomer, S Czurda, S Dulucq, H E Housni, L Eggen, G Gerrard, D Filomena, M Gniot, B Izzo, D Jacquin, J JWM Janssen, S Jeromin, T Jurcek, D-W Kim, K Machova-Polakova, J Martinez-Lopez, M McBean, S Mesanovic, G MitterbauerHohendanner, H Mobtaker, M-J Mozziconacci, T Pajic, N Pallisgaard, P Panagiotidis, R Press, Y-Z Qin, G Radich, T Sacha, T Touloumenidou, P Waits, E Wilkinson, R Zadro, M Mueller, A Hochhaus, S Branford 

Leukemia 2016 Sep;30(9):1844-52 

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma 

Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V, Schneider M, Yoshida K, Skaftason A, Pandzic T, Gonzalez B, Tasidou A, Waldhueter N, Rivas-Delgado A, Angelopoulou M, Ziepert M, Arends CM, Couronné L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J, Dörken B, Drexler HG, Roos-Weil D, Schmitt CA, Munch-Petersen HD, Zenz T, Hansmann ML, Strefford JC, Enblad G, Bernard OA, Ralfkiaer E, Erlanson M, Korkolopoulou P, Hultdin M, Papadaki T, Grønbæk K, Lopez-Guillermo A, Ogawa S, Küppers R, Stamatopoulos K, Stavroyianni N, Kanellis G, Rosenwald A, Campo E, Amini RM, Ott G, Vassilakopoulos TP, Hummel M, Rosenquist R, Damm F 

Blood. 2016 Dec 8; 128(23):2666-2670 

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations 

Ljungström V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, Ntoufa S, Baliakas P, Clifford R, Sutton LA, Blakemore SJ, Stavroyianni N, Agathangelidis A, Rossi D, Höglund M, Kotaskova J, Juliusson G, Belessi C, Chiorazzi N, Panagiotidis P, Langerak AW, Smedby KE, Oscier D, Gaidano G, Schuh A, Davi F, Pott C, Strefford JC, Trentin L, Pospisilova S, Ghia P, Stamatopoulos K, Sjöblom T, Rosenquist R 

Blood. 2016 Feb 25;127(8):1007-16 

PATHWAY-2: spironolactone for resistant hypertension 

E. Gkaliagkousi, E. Gavriilaki, A. Triantafyllou, S. Douma 

Lancet. 2016;387(10026):1372 

Understanding cardiovascular risk in hemophilia: A step towards prevention and management 

N Sousos, E Gavriilaki, S Vakalopoulou, V Garipidou 

Thromb Res. 2016;140:14-21 

Febuxostat hypersensitivity: another cause of DRESS syndrome in chronic kidney disease? 

E Paschou, E Gavriilaki, G Papaioannou, A Tsompanakou, A Kalaitzoglou, N Sabanis 

Eur Ann Allergy Clin Immunol. 2016 Nov;48(6):251-255 

Typical Hus: Evidence of Acute Phase Complement Activation from a Daycare Outbreak 

TM Brady, C Pruette, LF Loeffler, D Weidemann, JJ Strouse, E Gavriilaki, RA Brodsky 

Clin Exp Nephrol. 2016;1(2):11 

Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome 

AJ Vaught, E Gavriilaki, N Hueppchen, K Blakemore, X Yuan, SM Seifert, S York, RA Brodsky 

Exp Hematol. May 2016, Pages 390-398 

Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls in Vitro 

LC. Davies, JJ Alm, N. Heidrig, G Moll, C. Gavin, I. Batsis, H. Qian, M. Sigvardsson, B. Nilsson, LE Kyllonen, KT. Salmela, PO Carlsson, O. Korsgren, K Le Blanc 

Stem Cells Transl Med. 2016 Nov;5(11):1485-1495 

Selection of conditioning regimen. The role of age and comorbidities 

Sakellari 

Haema 2016; 7(2): 169-179 

Graft-versus-Ηost Disease: pathophysiology, clinical picture, prevention, and treatment 

Mallouri, I. Sakellari 

Haema 2016; 7(2): 180-190 

Indications and results of allogeneic stem cell transplantation in acute lymphoblastic leukemia and lymphoproliferative neoplasms 

P Kaloyannidis, I Sakellari 

Haema 2016; 7(2): 230-241

Δημοσιεύσεις εργασιών 2015

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis 

Nagler A, Savani BN, Labopin M, Polge E, Passweg J, Finke J, Kyrcz-Krzemien S, Volin L, Anagnostopoulos A, Aljurf M, Beelen DW, Vigouroux S, Milpied N, Suarez F, Mohty M 

Lancet Haematol 2015 Sep;2(9):e384-92 

Not all IGHV3-21 chronic lymphocytic leukemia are equal: prognostic considerations 

P. Baliakas, A. Agathangelidis, A. Hadzidimitriou, LA Sutton, E. Minga, A. Tsanousa, L. Scarfò, Z. Davis, X. Yan, T. Shanafelt, K. Plevova, Y. Sandberg, F. Vojdeman, M. Boudjogra, T. Tzenou, M. Chatzouli, C. Chu, S. Veronese, A. Gardiner, L. Mansouri, KE Smedby, L. Pedersen, D. Moreno, K. van Lom, V. Giudicelli, H. Francova, F. Nguyen-Khac, P. Panagiotidis, G. Juliusson, L. Angelis, A. Anagnostopoulos, MP Lefranc, M. Facco, L. Trentin, M. Catherwood, M. Montillo, C. Geisler, A. Langerak, S. Pospisilova, N. Chiorazzi, D. Oscier, D. Jelinek, N. Darzentas, C. Belessi, F. Davi, P. Ghia, R. Rosenquist, K. Stamatopoulos 

Blood 2015 Jan 29;125(5):856-9 

Recurrent mutations refine prognosis in chronic lymphocytic leukemia 

P.Baliakas, A. Hadzidimitriou, LA. Sutton LA, D. Rossi, E. Minga, N. Villamor, M. Larrayoz, J. Kminkova, A. Agathangelidis, Z. Davis, E. Tausch, E. Stalika, B. Kantorova, L. Mansouri, L. Scarfò, D. Cortese, V. Navrkalova, M. Rose-Zerilli, KE Smedby, G. Juliusson, A. Anagnostopoulos, AM Makris, A. Navarro, J. Delgado, D. Oscier, C. Belessi, S. Stilgenbauer, P. Ghia, S. Pospisilova, G. Gaidano, E. Campo, JC Strefford, K. Stamatopoulos, R. Rosenquist, European Research Initiative on CLL (ERIC) 

Leukemia. 2015 Feb;29(2):329-36 

Silent T-cell lymphoma of γδ T-cell origin initially presented as panniculitis 

Patsatsi, T. Koletsa, D. Sotiriadis, I. Batsis, I. Sakellari, A. Anagnostopoulos, T. Papadaki, I. Kostopoulos 

J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1244-5 

A certified plasmid reference material for the standardization of BCR-ABL1 mRNA quantification by real time quantitative PCR 

White, L. Deprez, P. Corbisier, V. Hall, F. Lin, S. Mazoua, S. Trapmann, A. Aggerholm, H. Andrikovics, S. Akiki, G. Barbany, N. Boeckx, A. Bench, M. Catherwood, J.-M. Cayuela, S. Chudleigh, T. Clench, D. Colomer, F. Daraio, S. Dulucq, J. Farrugia, L. Fletcher, L. Foroni, R. Ganderton, G. Gerrard, E. Gineikienė, S. Hayette, H. E. Housni, B. Izzo, M. Jansson, P. Johnels, T. Jurcek, V. Kairisto, A.  Kizilors, D.-W. Kim, T. Lange, T. Lion, K. M. Polakova, G. Martinelli, S. McCarron, P. A. Merle, B. Milner, G. Mitterbauer-Hohendanner, M. Nagar, G. Nickless, J. Nomdedéu, D. A. Nymoen, E. Oppliger Leibundgut, U. Ozbek, T. Pajič, H. Pfeifer, C. Preudhomme, K. Raudsepp, G. Romeo, T. Sacha, R. Talmaci, T. Touloumenidou, V. HJ Van der Velden, P. Waits, L. Wang, E. Wilkinson, G. Wilson,  D. Wren, R. Zadro, J. Ziermann, K. Zoi, M. C. Müller, A. Hochhaus, H. Schimmel, N. C. P. Cross, H. Emons 

Leukemia. 2015 Feb;29(2):369-76 

An entity evolving into a community: defining the common ancestor and evolutionary trajectory of chronic lymphocytic leukemia stereotyped subset #4 

LA Sutton, G. Papadopoulos, A. Hadzidimitriou, S. Papadopoulos, E. Kostareli, R. Rosenquist, D. Tzovaras, K. Stamatopoulos 

Mol Med. 2015 Apr 2;20(1):720-8 

Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas 

Ι. Sakellari, D. Mallouri, I. Batsis, C. Apostolou, V. Konstantinou, EM. Abela, V. Douka, A. Marvaki, K. Karypidis, M. Iskas, P. Baliakas, P. Kaloyannidis, E. 

Yannaki, D. Sotiropoulos, G. Kouvatseas, C. Smias, A. Anagnostopoulos 

Leuk Lymphoma 2015 Nov;56(11):3071-81 

A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation 

Sakellari, M. Angelopoulou, O. Tsopra, I. Dervenoulas, P. Tsirigotis, A. Spyridonidis, M. Liga, K. Tsionos, K. Anargyrou, A. Pouli, A. Anagnostopoulos 

Ann Hematol 2015 Oct;94(10):1733-40 

Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy 

G Karponi, N Psatha, CW Lederer, JE Adair, F Zervou, N Zogas, M Kleanthous, 

C Tsatalas, A Anagnostopoulos, M Sadelain, I Rivière, G Stamatoyannopoulos, 

E.Yannaki 

Blood 2015 Jul 30;126(5):616-9 

Molecular evidence for antigen drive in the natural history of mantle cell lymphoma 

Xochelli, L.A. Sutton, A. Agathangelidis, E. Stalika, M. Karypidou, F. Marantidou, A.N. Lopez, G. Papadopoulos, J. Supikova, P. Groenen, M. Boudjogra, C. Sundstrom, M. Ponzoni, H.S. Francova, A. Anagnostopoulos, S. Pospisilova, T. Papadaki, D. Tzovaras, P. Ghia, C. Pott, F. Davi, E. Campo, R. Rosenquist, A. Hadzidimitriou, C. Belessi, K. Stamatopoulos 

Am J Pathol 2015 Jun;185(6):1740-8 

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing 

M. Parry, M. Rose-Zerilli, V. Ljungström, J. Gibson, J. Wang, R. Walewska, H. Parker, A. Parker, Z. Davis, A. Gardiner, N. McIver-Brown, C. Kalpadakis, A. Xochelli, A. Anagnostopoulos, C. Fazi, D. Gonzalez de Castro, C. Dearden, G. Pratt, R. Rosenquist, M. Ashton-Key, F. Forconi, A. Collins, P. Ghia, E. Matutes, G. Pangalis, K. Stamatopoulos, D. Oscier, J. Strefford 

Clin Cancer Res 2015 Sep 15;21(18):4174-83 

In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice 

M. Samalidou, D. Bougiouklis, TA. Vyzantiadis, J. Meletiadis, N. Monokrousos, E. Siotou, A. Sivropoulou, A. Anagnostopoulos, D. Sotiropoulos 

Exp Biol Med. 2015 Dec; 240(12):1728-34 

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience 

Katodritou E, Terpos E, Kastritis E, Delimpasi S, Symeonidis AS, Repousis P, Kyrtsonis MC, Vadikolia C, Michalis E, Polychronidou G, Michael M, Papadaki S, Papathanasiou M, Kokoviadou K, Kioumi A, Vlachaki E, Hadjiaggelidou C, Kouraklis A, Patsias I, Gavriatopoulou M, Kotsopoulou M, Verrou E, Gastari V, Christoulas D, Giannopoulou E, Pouli A, Konstantinidou P, Anagnostopoulos A, Dimopoulos MA 

Ann Hematol 2015 Dec; 94(12):2033-42 

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia 

Moreno, M. Montillo, P. Panayiotidis, M. Dimou, A. Bloor, J. Dupuis, A. Schuh, S. Norin, C. Geisler, P. Hillmen, M. Doubek, M. Trněný, P. Obrtlikova, L. Laurenti L, S. Stilgenbauer, L. Smolej, P. Ghia, F. Cymbalista, U. Jaeger, K. Stamatopoulos, N. Stavroyianni, P. Carrington, H. Zouabi, V. Leblond, JC Gomez-Garcia, M.  Rubio, R. Marasca, G. Musuraca, L. Rigacci, L. Farina, R. Paolini, S. Pospisilova, E. Kimby, C. Bradley, E. Montserrat 

Haematologica 2015 Apr;100(4):511-6 

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting 

LA Sutton, V. Ljungström, L. Mansouri, E. Young, D. Cortese, V. Navrkalova, J. Malcikova, A. Muggen, M. Trbusek, P. Panagiotidis, F. Davi, C. Belessi, A. 

Langerak, P. Ghia, S. Pospisilova, K. Stamatopoulos, R. Rosenquist 

Haematologica 2015 Mar;100(3):370-6 

Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia 

Xochelli, A. Agathangelidis, I. Kavakiotis, E. Minga, L.A. Sutton, P. Baliakas, I. Chouvarda, V. Giudicelli, I. Vlahavas, N. Maglaveras, L. Bonello, L. Trentin, A. Tedeschi, P. Panagiotidis, C. Geisler, A.W. Langerak, S. Pospisilova, D.F. Jelinek, D. Oscier, N. Chiorazzi, N. Darzentas, F. Davi, P. Ghia, R. Rosenquist, A. Hadzidimitriou, C. Belessi, M.P. Lefranc, K.  Stamatopoulos 

Immunogenetics 2015 Jan; 67(1):61-6 

Stem cell-based regenerative opportunities for the liver: state of the art and beyond 

E. Tsolaki, E. Yannaki 

World J Gastroenterol 2015 Nov 21;21(43):12334-50 

A treacherous case of primary non-Hodgkin lymphoma of the bone: appearances can be deceptive 

P.Anyfanti, E. Gouridou, A. Tsinaridis, D. Bekiaropoulos, E. Argyropoulos, N. Sousos, I. Petrou, M. Papathanasiou, A. Morichovitou, G. Damianidis, S. Bakatselos 

Scott Med J2015 Aug;60(3):e9-13

Δημοσιεύσεις εργασιών 2014

Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes 

M. Chatzouli, S. Ntoufa, N. Papakonstantinou, E. Chartomatsidou, A. Anagnostopoulos, P. Kollia, P. Ghia, M. Muzio, K. Stamatopoulos, C. Belessi 

J Immunol 2014 May 15; 192(10):4518-24 

Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma 

E. Stalika, G. Kanellis, A. Papalexandri, M. Iskas, E. Vrakidou, M. Demonakou, A. Anagnostopoulos, K. Stamatopoulos, T. Papadaki 

Leuk Lymphoma 2014 Mar;55(3):702-5 

Chromosomal translocations and karyotype complexity in CLL: A systematic reappraisal of classic cytogenetic data 

P. Baliakas, M. Iskas, A. Gardiner, Z. Davis, K. Plevova, F. Nguyen-Khac, J. Malcikova, A. Anagnostopoulos, S. Glide, S. Mould, K. Stepanovska, M. Brejcha, C. Belessi, F. Davi, S. Pospisilova, A. Athanasiadou, K. Stamatopoulos, D. Oscier 

Am J Hematol. 2014 Mar;89(3):249-55 

Familial CD3+ T Large Granular Lymphocyte Leukemia: Evidence that Genetic Predisposition and Antigen Selection Promote Clonal Cytotoxic T-Cell Responses 

E. Stalika, A. Papalexandri, M. Iskas, N. Stavroyianni, G. Kanellis, K. Kotta, C. Pontikoglou, A. Siorenta, A. Anagnostopoulos, H. Papadaki, T. Papadaki, K. Stamatopoulos 

Leuk Lymphoma 2014 Aug;55(8):1781-7 

IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: Ontogenetic implications 

Vardi, A. Agathangelidis, LA Sutton, M. Chatzouli, L. Scarfo, L. Mansouri, V. Douka, A. Anagnostopoulos, N. Darzentas, R. Rosenquist, P. Ghia, C. Belessi, K. Stamatopoulos 

Clin Cancer Res 2014 Jan 15;20(2):323-30 

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal zone origin: is this a distinct entity? 

Xochelli, C. Kalpadakis, A. Gardiner, P. Baliakas, TP Vassilakopoulos, S. Mould, Z. Davis, E. Stalika, G. Kanellis, MK Angelopoulou, N. McIver-Brown, R. Ibbotson, S. Sachanas, P. Korkolopoulou, A. Athanasiadou, A. Anagnostopoulos, HA Papadaki, T. Papadaki, K. Stamatopoulos, GA Pangalis, D. Oscier 

Blood 2014 Feb 20;123(8):1199-206 

Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury 

E. Tsolaki, E. Athanasiou, E. Gounari, N. Zogas, E. Siotou, M. Yiangou, A. Anagnostopoulos, E. Yannaki 

Blood Cells Mol Dis 2014 Sep;53(3):124-32 

“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group 

Katodritou E, Vadikolia C, Lalagianni C, Kotsopoulou M, Papageorgiou G, Kyrtsonis M-C, Matsouka P, Giannakoulas N, Kyriakou D, Karras G, Anagnostopoulos N, Michali E, Briasoulis E, Hatzimichael E, Spanoudakis E, Zikos P, Tsakiridou A, Tsionos K, Anargyrou K, Symeonides A, Maniatis A, Terpos E 

Ann Hematol, 2014 Jan;93(1):129-39 

Congenital Acute Lymphoblastic Leukemia Case with a Novel t(2:4:11) (p21:q21:q23) translocation 

E. Hatzipantelis, ZD. Pana, T. Papageorgiou, M. Hatzistilianou, A. Athanasiadou, K. Sarafidis, V. Tsotoulidou, G. Papaioannou, F. Athanassiadou 

Pediatr Hematol Oncol. 2014 Mar;31(2):178-80 

Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia 

L. Mansouri, LA Sutton, V. Ljungström, EF Sörqvist, R. Gunnarsson, KE Smedby, G. Juliusson, K. Stamatopoulos, M. Nilsson, R. Rosenquist 

Leukemia. 2014 Mar;28(3):694-6 

Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group 

E. Katodritou, E. Terpos, C. Kelaidi, M. Kotsopoulou, S. Delimpasi, M.C. Kyrtsonis, A. Symeonidis, N. Giannakoulas, A. Stefanoudaki, D. Christoulas, C. Chatziaggelidou, V. Gastari, N. Spyridis, E. Verrou, P. Konstantinidou, K. Zervas, M.A. Dimopoulos 

Am J Hematol. 2014 Feb;89(2):145-50 

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors 

Malcikova, E. Stalika, Z. Davis, K. Plevova, M. Trbusek, L. Mansouri, L. Scarfò, P. Baliakas, A. Gardiner, LA Sutton, H. Francova, A. Agathangelidis, A. Anagnostopoulos, I. Tracy, A. Makris, J. Smardova, P. Ghia, C. Belessi, D. Gonzalez, R. Rosenquist, D. Oscier, S. Pospisilova, K. Stamatopoulos 

Br J Haematol. 2014 Aug; 166(4):621-5 

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study 

P. Baliakas, A. Hadzidimitriou, LA. Sutton, E. Minga, A. Agathangelidis, A. Tsanousa, L. Scarfo, Z. Davis, X. Yan, T. Shanafelt, K. Plevova, Y. Sandberg, F. Vojdeman, M. Boudjogra, T. Tzenou, M. Chatzouli, C. Chu, S. Veronese, A. Gardiner, L. Mansouri, K. Smedby, L. Pedersen, D. Moreno, K. van Lom, V. Giudicelli, H. Francova, F. Nguyen-Khac, P. Panagiotidis, G. Juliusson, L. Angelis, A. Anagnostopoulos, MP Lefranc, M. Facco, L. Trentin, M. Catherwood, M. Montillo, C. Geisler, A. Langerak, S. Pospisilova, N. Chiorazzi, D. Oscier, D. Jelinek, N. Darzentas, C. Belessi, F. Davi, R. Rosenquist, P. Ghia, K. Stamatopoulos 

Lancet Haematol 2014; 1(2):74-84 

Maritime route of colonization in Europe 

P Paschou, P Drineas, E Yannaki, A Razou, K Kanaki, F Tsetsos, SS Padmanabhuni, M Michalodimitrakis, MC Renda, S Pavlovic, A Anagnostopoulos, JA Stamatoyannopoulos, KK Kidd, G Stamatoyannopoulos 

Proc Natl Acad Sci U S A 2014 Jun 24;111(25):9211-6 

Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbbth-3 Mouse Model 

N Psatha, E Sgouramali, A Gountis, AP Siametis, P Baliakas, V Constantinou, E Athanasiou, M Arsenakis, A Anagnostopoulos, T Papayannopoulou, G Stamatoyannopoulos, E Yannaki 

Hum Gene Ther Methods 2014 Dec;25(6):317-27 

Specific abnormalities versus number of abnormalities and cytogenetic scoringsystems for outcome prediction after allogeneic hematopoietic SCT formyelodysplastic syndromes 

Kelaidi, I. Tzannou, I. Baltadakis, I. Batsis, D. Mallouri, A. Spyridonidis, S. Gigantes, P. Tsirigotis, I. Apostolidis, A. Athanasiadou, K. Manola, A. Anagnostopoulos, N. Harhalakis, I. Sakellari, D. Karakasis 

Bone Marrow Transplant. 2014 Aug;49(8):1022-8 

“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group 

E. Katodritou, Vadikolia C, Lalagianni C, Kotsopoulou M, Papageorgiou G, Kyrtsonis M-C, Matsouka P, Giannakoulas N, Kyriakou D, Karras G, Anagnostopoulos N, Michali E, Briasoulis E, Hatzimichael E, Spanoudakis E, Zikos P, Tsakiridou A, Tsionos K, Anargyrou K, Symeonides A, Maniatis A, E. Terpos 

Ann Hematol. 2014 Jan;93(1):129-39 

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients 

E Katodritou, Terpos E, Symeonidis AS, Pouli A, Kelaidi C, Kyrtsonis MC, Kotsopoulou M, Delimpasi S, Christoforidou A, Giannakoulas N, Viniou NA, Stefanoudaki E, Hadjiaggelidou C, Christoulas D, Verrou E, Gastari V, Papadaki S, Polychronidou G, Papadopoulou A, Giannopoulou E, Kastritis E, Kouraklis A, Konstantinidou P, Anagnostopoulos A, Zervas K, MA. Dimopoulos 

Am J Hematol. 2014 Aug;89(8):803-8 

Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution 

Α. Vardi, Α. Agathangelidis, LA Sutton, P. Ghia, R. Rosenquist, K. Stamatopoulos 

Cancer Res. 2014 Aug 15; 74(16):4211-6 

Translocation t (2; 7) (p11.2; q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone origin 

Xochelli, P. Baliakas, S. Moore, F. Sole, N. Wickham, M. Salido, A. Athanasiadou, D. Oscier, K. Stamatopoulos 

Cancer Genet. 2014 Jun 25; 207(6):281-3 

Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma 

Gebhart, K. Lechner, C. Skrabs, T. Sliwa, E. Müldür, H. Ludwig, T. Nösslinger, K. Vanura, K. Stamatopoulos, I. Simonitsch-Klupp, A. Chott, P. Quehenberger, G. Mitterbauer-Hohendanner, I. Pabinger, U. Jäger, K. Geissler 

Thromb Res. 2014 Nov;134(5):980-4 

Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia 

AC Bergh, C. Evaldsson, LB Pedersen, C. Geisler, K. Stamatopoulos, R. Rosenquist, A. Rosén 

Haematologica. 2014 Nov; 99(11):1722-30 

Stereotyped B-cell receptors in chronic lymphocytic leukemia 

Agathangelidis, A. Vardi, P. Baliakas, K. Stamatopoulos 

Leuk Lymphoma. 2014 Oct; 55(10):2252-61 

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies 

Gamaletsou MN, Walsh TJ, Zaoutis T, Pagoni M, Kotsopoulou M, Voulgarelis M, Panayiotidis P, Vassilakopoulos T, Angelopoulou MK, Marangos M, Spyridonidis A, Kofteridis D, Pouli A, Sotiropoulos D, Matsouka P, Argyropoulou A, Perloretzou S, Leckerman K, Manaka A, Oikonomopoulos P, Daikos G, Petrikkos G, Sipsas NV 

Clin Microbiol Infect. 2014 Jan; 20(1):O50-7 

Systemic inflammatory response syndrome after administration of unmodified T lymphocytes 

A Papadopoulou, RA Krance, CE Allen, D Lee, CM Rooney, MK Brenner, A. Μ. Leen, HE Heslop 

Mol Ther. 2014 Jun; 22(6):1134-8 

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT 

Papadopoulou, U. Gerdemann, UL Katari, I. Tzannou, H. Liu, C. Martinez, K. Leung, G. Carrum, and AP Gee, JF Vera, RA Krance, MK Brenner, CM Rooney, HE Heslop, and AM Leen 

Sci Transl Med. 2014 Jun 25; 6(242):242ra83

Δημοσιεύσεις εργασιών 2013

An outbreak of Burkholderia cepacia bacteremia in hospitalized hematology patients selectively affecting those with acute myeloid leukemia 

Vardi, A. Sirigou, C. Lalayanni, M. Kachrimanidou, P. Kaloyannidis, R. Saloum, A. Anagnostopoulos, D. Sotiropoulos 

Am J Infect Control 2013 Apr;41(4):312-6 

The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal 

P. Baliakas, G. Kanellis, N. Stavroyianni, M. Fameli, A. Anagnostopoulos, K. Stamatopoulos, T. Papadaki 

Leuk Lymphoma 2013 Nov;54(11):2377-84 

Molecular evidence for repertoire skewing of T large granular lymphocyte proliferation after allogeneic hematopoietic SCT: report of two cases 

Papalexandri, E. Stalika, M. Iskas, M. Karypidou, P. Zerva, T. Touloumenidou, V. Tachynopoulou, I. Batsis, T. Papadaki, I. Sakellari, A. Anagnostopoulos, K. Stamatopoulos 

Bone Marrow Transplant 2013 Sep;48(9):1260-1 

Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia 

N. Papakonstantinou, S. Ntoufa, E. Chartomatsidou, G. Papadopoulos, A. Hatzigeorgiou, A. Anagnostopoulos, K. Chlichlia, P. Ghia, M. Muzio, C. Belessi, K. Stamatopoulos 

Mol Med 2013 May 20;19:115-23 

Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence 

LA Sutton, E. Kostareli, E. Stalika, A. Tsaftaris, A. Anagnostopoulos, N. Darzentas, R. Rosenquist, K. Stamatopoulos 

Mol Med. 2013 Aug 28;19:230-6 

Hematopoietic stem cell mobilization for gene therapy: superior mobilization by the combination of G-CSF plus plerixafor in patients with thalassemia major 

E. Yannaki, G. Karponi, F. Zervou, V. Constantinou, A. Bouinta, V. Tachynopoulou, K. Kotta, E. Jonlin, T. Papayannopoulou, A. Anagnostopoulos, G. Stamatoyannopoulos 

HumGeneTher.2013; 24:852-60 

GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation 

Sakellari, K. Barbouti, G. Bamichas, D. Mallouri, P. Kaloyannidis, S. Fragidis, I. Batsis, C. Apostolou, A. Karpouza, E. Yannaki, C. Smias, K. Sombolos, A. Anagnostopoulos 

Bone Marrow Transplant. 2013;48(10):1329-34 

Autologous HSCT for systemic sclerosis 

Ι. Sakellari, E. Gavriilaki, D. Mallouri, I. Batsis, A. Anagnostopoulos 

Lancet 2013; 381(9883):2080 

An unusual cluster of Acremonium kiliense fungaemias in a haematopoietic cell transplantation unit 

A Ioakimidou, TA Vyzantiadis, I Sakellari, M Arabatzis, C Smias, V Douka, A Velegraki, A Anagnostopoulos, N Malissiovas 

Diagn Microbiol Infect Dis. 2013 Mar;75(3):313-6 

Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury 

Xagorari, E. Siotou, M. Yiangou, E. Tsolaki, D. Bougiouklis, L. Sakkas, A. Fassas, A. Anagnostopoulos 

Int J Clin Exp Pathol. 2013 Apr 15;6(5):831-40 

Stereotyped B cell receptors in B cell leukemias and lymphomas 

N. Darzentas, K Stamatopoulos 

Methods Mol Biol. 2013;971:135-48 

Targeting the LYN/HS1signaling axis in chronic lymphocytic leukemia 

E. tenHacken, C.  Scielzo, MT Bertilaccio, L. Scarfò, B. Apollonio, F. Barbaglio, K. Stamatopoulos, M. Ponzoni, P. Ghia, F. Caligaris-Cappio 

Blood. 2013 Mar21;121(12):2264-73 

Antigen selection in B-cell lymphomas–tracing the evidence 

LA Sutton, A. Agathangelidis, C. Belessi, N. Darzentas, F. Davi, P. Ghia, R Rosenquist, K. Stamatopoulos 

Semin Cancer Biol. 2013 Dec;23(6):399-409 

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome 

E. Chigrinova, A. Rinaldi, I. Kwee, D. Rossi, PM Rancoita, JC Strefford, D. Oscier, K. Stamatopoulos, T. Papadaki, F. Berger, KH Young, F. Murray, R. Rosenquist, TC Greiner, WC Chan, EM Orlandi, M. Lucioni, R. Marasca, G. Inghirami, M. Ladetto, F. Forconi, S Cogliatti, H. Votavova, SH Swerdlow, S. Stilgenbauer, MA Piris, A. Matolcsy, D. Spagnolo, E. Nikitin, A. Zamò, V. Gattei, G. Bhagat, G. Ott, E. Zucca, G. Gaidano, F. Bertoni 

Blood. 2013 Oct 10;122(15):2673-82 

B Cell Receptor and Antigens in CLL 

Agathangelidis, S. Ntoufa, K. Stamatopoulos 

AdvExp Med Biol. 2013;792:1-24 

Antigens in lymphoma development–current knowledge and future directions 

R. Rosenquist, F. Davi, K. Stamatopoulos 

Semin Cancer Biol. 2013 Dec;23(6):397-8 

A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma 

M. Kanduri, B. Sander, S. Ntoufa, N. Papakonstantinou, LA Sutton, K. Stamatopoulos, C. Kanduri, R. Rosenquist 

Epigenetics. 2013 Dec;8(12):1280-8 

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2 

JC Strefford, LA Sutton, P. Baliakas, A. Agathangelidis, J. Malčíková, K. Plevova, L. Scarfó, Z. Davis, E. Stalika, D. Cortese, N. Cahill, LB Pedersen, PF di Celle, T. Tzenou, C. Geisler, P. Panagiotidis, AW Langerak, N. Chiorazzi, S Pospisilova, D. Oscier, F. Davi, C. Belessi, L. Mansouri, P. Ghia, K. Stamatopoulos, R. Rosenquist 

Leukemia. 2013 Nov;27(11):2196-9 

The significance of stereotyped B-cell receptors in chronic lymphocytic leukemia 

N. Darzentas, K. Stamatopoulos 

Hematol Oncol Clin North Am. 2013 Apr;27(2):237-50 

Immunogenetics shows that not all MBL are equal: the larger the clone, the moresimilar to CLL 

Vardi, A. Dagklis, L. Scarfò, D. Jelinek, D. Newton, F. Bennett, J. Almeida, A. Rodriguez-Caballero, S. Allgood, M. Lanasa, A. Cortelezzi, E. Orlandi, S. Veronese, M. Montillo, A. Rawstron, T. Shanafelt, A. Orfao, K. Stamatopoulos, P. Ghia 

Blood. 2013 May 30;121(22):4521-8 

Expression of Ig receptors with distinctive features indicating antigen selection by marginal zone B cells from human spleen 

M. Colombo, G. Cutrona, D. Reverberi, S. Bruno, F. Ghiotto, C. Tenca, K. Stamatopoulos, A. Hadzidimitriou, J. Ceccarelli, S. Salvi, S. Boccardo, MG Calevo, A. De Santanna, M. Truini, F. Fais, M. Ferrarini 

Mol Med. 2013 Sep 17;19(1):294-302 

Chronic lymphocytic leukemia patients have a preserved cytomegalovirus-specific antibody response despite progressive hypogammaglobulinemia 

K. Vanura, F. Rieder, MT Kastner, J. Biebl, M. Sandhofer, T. Le, R. Strassl, E. Puchhammer-Stöckl, T. Perkmann, CF Steininger, K. Stamatopoulos, W. Graninger, U. Jäger, C. Steininger 

PLoS One. 2013 Oct 23;8(10):e78925 

High frequency of NAD(P)H:quinone oxidoreductase 1 (NQO1) C(609)T germline polymorphism in MDS/AML with trisomy 8 

S. Zachaki, C. Stavropoulou, T. Koromila, KN. Manola, M. Kalomoiraki, A. Daraki, D. Koumbi, A. Athanasiadou, E. Kanavakis, P. Kollia, C. Sambani. 

Leuk Res. 2013;37(7):742-746 

Treatment of Chronic Lymphocytic Leukemia 

N. Stavroyianni 

Haema 2013; 4(2):144-150 

Classic and molecular cytogenetic analysis of B chronic lymphoproliferative disorders 

Athanasiadou 

Haema 2013; 4(2):128-134

Δημοσιεύσεις εργασιών 2012

Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β- thalassemia: Results of clinical trials using G-CSF or plerixafor in splenectomized and non-splenectomized subjects 

Yannaki T. Papayannopoulou., E. Jonlin, F. Zervou, G. Karponi, A. Xagorari, P. Becker, N. Psatha, I. Batsis, P. Kaloyannidis, V. Tahynopoulou, V. Constantinou, M. Bouida, K. Kotta, A. Athanassiadou, A. Anagnostopoulos, A. Fassas, G.Stamatoyannopoulos 

Mol Ther 2012 Jan; 20(1):230-8 

Coexistence of trisomies of chromosomes 12 and 19 in chronic lymphocytic leukemia occurs exclusively in the rare IgG-positive variant 

R. Ibbotson, A. Athanasiadou, L.A. Sutton, Z. Davis, A. Gardiner, P. Baliakas, R. Gunnarsson, A. Anagnostopoulos, G. Juliusson, R. Rosenquist, D. Oscier, K. Stamatopoulos 

Leukemia 2012 Jan; 26(1):170-2 

Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications 

V. Bikos, N. Darzentas, A. Hadzidimitriou, Z. Davis, S. Hockley, A. Traverse-Glehen, P. Algara, A. Santoro, D. Gonzalez, M. Mollejo, A. Dagklis, F. Gangemi, D.S. Bosler, G. Bourikas, A. Anagnostopoulos, A. Tsaftaris, E. Iannitto, M. Ponzoni, P. Felman, F. Berger, C. Belessi, P. Ghia, T. Papadaki, A. Dogan, M. Degano, E. Matutes, M.A. Piris, D. Oscier, K. Stamatopoulos 

Leukemia 2012 Jul;26(7):1638-46 

Extracorporeal photopheresis in refractory chronic graft-versus-host disease: The influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology 

P. Tsirigotis, V. Kapsimalli, I. Baltadakis, P. Kaloyannidis, D. Karakasis, A. Papalexandri, E. Psarra, E. Nosi, E. Konsta, M. Vikentiou, S. Papageorgiou, I. Sakellari, V. Pappa, N. Harhalakis, A. Anagnostopoulos, J. Dervenoulas 

Transfus Apher Sci 2012 Apr;46(2):181-8 

Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology 

P. Tsirigotis, P. Kaloyannidis, A. Papalexandri, I. Baltadakis, D. Karakasis, I. Batsis, I. Sakellari, V. Kitra, E. Goussetis, S. Papageorgiou, A. Spyridonidis, S. Graphakos, N. Harhalakis, I. Dervenoulas, A. Anagnostopoulos 

Transfus Apher Sci 2012 Apr;46(2):173-80 

Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity 

Kostareli, M. Gounari, A. Janus, F. Murray, X. Brochet, V. Giudicelli, S. Pospisilova, D. Oscier, L. Foroni L, P. F. di Celle, B. Tichy, L. B. Pedersen, J. Jurlander, M. Ponzoni, A. Kouvatsi, A. Anagnostopoulos, K. Thompson, N. Darzentas, M. P. Lefranc, C. Belessi, R. Rosenquist, F. Davi, P. Ghia, K. Stamatopoulos 

Leukemia 2012 May;26(5):1127-31 

Outcomes of Hodgkin’s Lymphoma Patients with Relapse or Progression following Autologous Hematopoietic Cell Transplantation 

P. Kaloyannidis, G. Voutiadou, I. Baltadakis, P. Tsirigotis, A. Spyridonidis, P. Repousis, A. Balta, S. Tsimberis, D. Karakasis, I. Sakellari, I. Dervenoulas, N. Harhalakis, A. Anagnostopoulos 

Biol Blood Marrow Transplant 2012 Mar;18(3):451-7 

The role of the extracorporeal photopheresis in the management of the graft-versus-host disease 

P. Kaloyannidis, D. Mallouri 

Transfus Apher Sci 2012 Apr;46(2):211-9 

Partial versus Productive IGH Locus Rearrangements in Chronic Lymphocytic Leukemia: Implications for B-Cell Receptor Stereotypy 

Tsakou, A. Agathagelidis, M. Boudjoghra, T. Raff, A. Dagklis, M. Chatzouli, T. Smilevska, G. Bourikas, H. Merle-Beral, E. Manioudaki-Kavallieratou, A. Anagnostopoulos, M. Bruggemann, F. Davi, K. Stamatopoulos, C. Belessi 

Mol Med 2012 Feb 10;18(1):138-45 

Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis 

Papadopoulou, M. Yiangou, E. Athanasiou, N. Zogas, P. Kaloyannidis, I. Batsis,A. Fassas, A. Anagnostopoulos, E. Yannaki 

Ann Rheum Dis 2012 Oct; 71(10):1733-40 

Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation 

Dagklis, M. Ponzoni, S. Govi, MG Cangi, E. Pasini, F. Charlotte, A. Vino, C. Doglioni, F. Davi, IS Lossos, I. Ntountas, T. Papadaki, R. Dolcetti, AJ Ferreri, K. Stamatopoulos, P. Ghia 

Leukemia 2012 Apr;26(4):814-21 

Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia 

AM Halldorsdottir, M. Kanduri, M. Marincevic, L. Mansouri, A. Isaksson, H. Guransson, T. Axelsson, P. Agarwal, H. Jernberg-Wiklund, K. Stamatopoulos, B. Sander, H. Ehrencrona, R. Rosenquist 

Am J Hematol 2012 Apr;87(4):361-7 

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies 

Agathangelidis, N. Darzentas, A. Hadzidimitriou, X. Brochet, F. Murray, XJ Yan, Z. Davis, EJ van Gastel-Mol, C. Tresoldi, CC Chu, N. Cahill, V. Giudicelli, B. Tichy, LB Pedersen, L. Foroni, L. Bonello, A. Janus, K. Smedby, A. Anagnostopoulos, H. Merle-Beral, N. Laoutaris, G. Juliusson, PF di Celle, S. Pospisilova, J. Jurlander, C. Geisler, A. Tsaftaris, MP Lefranc, AW Langerak, D. Oscier, N. Chiorazzi, C. Belessi, F. Davi, R. Rosenquist, P. Ghia, K. Stamatopoulos 

Blood 2012 May 10;119(19):4467-75 

KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia 

T. Shinawi, V. Hill, A. Dagklis, P. Baliakas, K. Stamatopoulos, A. Agathanggelou, T. Stankovic, ER Maher, P. Ghia, F. Latif 

Epigenetics 2012 Mar;7(3):211-5 

Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors 

S. Ntoufa, A. Vardi, N. Papakonstantinou, A. Anagnostopoulos, V. Aleporou-Marinou, C. Belessi, P. Ghia, F. Caligaris-Cappio, M. Muzio, K. Stamatopoulos 

Mol Med 2012 Dec 6;18:1281-91 

Screening for cytotoxic compounds in poor-prognostic chronic lymphocytic leukemia 

M. Norberg, E. Lindhagen, M. Kanduri, L. Rickardson, C. Sundstrom, K. Stamatopoulos, R. Rosenquist, A. Öleskog 

Anticancer Res 2012 Aug;32(8):3125-36 

Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire 

V. Bikos, E. Stalika, P. Baliakas, N. Darzentas, Z. Davis, A. Traverse-Glehen, A. Dagklis, G. Kanellis, A. Anagnostopoulos, A. Tsaftaris, M. Ponzoni, F. Berger, P. Felman, P. Ghia, T. Papadaki, D. Oscier, C. Belessi, K. Stamatopoulos 

Leukemia 2012 Dec;26(12):2567-9 

Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features 

Navarro, G. Clot, C. Royo, P. Jares P, A. Hadzidimitriou, A. Agathangelidis, V. Bikos, N. Darzentas, T. Papadaki, I. Salaverria, M. Pinyol, X. Puig, J. Palomero, MC Vegliante, V. Amador, A. Martinez-Trillos, L. Stefancikova, A. Wiestner, W. Wilson, C. Pott, MJ Calasanz, N. Trim, W. Erber, B. Sander, G. Ott, A. Rosenwald, D. Colomer, E. Gine, R. Siebert, A. Lopez-Guillermo, K. Stamatopoulos, S. Bea, E. Campo 

Cancer Res 2012 Oct 15;72(20):5307-16 

Immunoglobulin gene repertoire in chronic lymphocytic leukemia: insight into antigen selection and microenvironmental interactions 

E. Kostareli, M. Gounari, A. Agathangelidis, K. Stamatopoulos 

Mediterr J Hematol Infect Dis 2012;4(1):e2012052 

Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology? 

M. Ponzoni, G. Kanellis, E. Pouliou, P. Baliakas, L. Scarfo, AJ Ferreri, C. Doglioni, V. Bikos, A. Dagklis, A. Anagnostopoulos, P. Ghia, K. Stamatopoulos, T. Papadaki 

Am J Surg Pathol 2012 Nov;36(11):1609-18 

Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles 

M. Kanduri, M. Marincevic, AM Halldorsdottir, L. Mansouri, K. Junevik, S. Ntoufa, HG Kultima, A. Isaksson, G. Juliusson, PO Andersson, H. Ehrencrona, K. Stamatopoulos, R. Rosenquist 

Epigenetics 2012 Dec 1;7(12):1435-42 

Monosomal karyotype in acute myeloid leukemia defines a distinct subgroup within the adverse cytogenetic risk category 

Voutiadou, G. Papaioannou, M. Gaitatzi, C. Lalayanni, A. Syrigou, C. Vadikoliou, R. Saloum, A. Anagnostopoulos, A. Athanasiadou 

Cancer Genet Jan-Feb 2013;206(1-2):32-6 

Outbreak of cutaneous zygomycosis associated with the use of adhesive tape in haematology patients 

Lalayanni, P. Baliakas, A. Xochelli, C. Apostolou, M. Arabatzis, A. Velegraki, A. Anagnostopoulos 

J Hosp Infect 2012 Jul;81(3):213-5 

T cell therapy: a powerful tool for the management of viral infections and relapse post hematopoietic stem cell transplantation 

P. Kaloyannidis, AM. Leen and A. Papadopoulou 

Expert Rev Hematol. 2012 Oct; 5(5):471-3 

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study 

U. Germing, M. Lauseker, B. Hildebrandt, A. Symeonidis, J. Cermak, P. Fenaux, C. Kelaidi, M. Pfeilstöcker, T. Nösslinger, M. Sekeres, J. Maciejewski, D. Haase, J. Schanz, J. Seymour, M. Kenealy, R. Weide, M. Lübbert, U. Platzbecker, P. Valent, K. Götze, R. Stauder, S. Blum, K.A. Kreuzer, R. Schlenk, A. Ganser, W.K. Hofmann, C. Aul, O. Krieger, A. Kündgen, R. Haas, J. Hasford, A. Giagounidis 

Leukemia 2012 Jun;26(6):1286-92 

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies 

L. Adès, F. Le Bras, M. Sebert, C. Kelaidi, T. Lamy, F. Dreyfus, V. Eclache, J. Delaunay, D. Bouscary, S. Visanica, P. Turlure, A.G. Bresler, M.P. Cabrol, A. Banos, M. Blanc, N. Vey, A. Delmer, E. Wattel, S. Chevret, P. Fenaux 

Haematologica 2012 Feb;97(2):213-8 

Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation 

L von Bahr, I Batsis, G Moll, M Hagg, A Szakos, B Sundberg, M Uzunel, O Ringden, K Le Blanc 

Stem Cells 2012 Jul; 30(7):1575-8 

Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience 

MP. Siakantaris, P. Tsirigotis, N. Stavroyianni, KV. Argyropoulos, K. Girkas, V. Pappa, S. Chondropoulos, E. Papadavid, I. Sakellari, A. Anagnostopoulos, C. Antoniou, J. Dervenoulas 

Transfus Apher Sci. 2012 Apr;46(2):189-93 

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes 

Sakellari 

Haema 2012; 3(2): 175-182 

Allogeneic hematopoietic stem cell (allo-HSCT) transplantation in Hodgkin lymphoma 

P. Kaloyannidis1, P. Tsirigotis2, I. Sakellari 

Haema 2012; 3(3): 266-274

Δημοσιεύσεις εργασιών 2011

Derivative (1;7) (q10;p10) in two patients with myelodysplastic syndrome after autologous haematopoietic cell transplantation 

Papaioannou. I.  Batsis, F. Iordanidis, C. Vadikoliou, P, Kaloyannidis, A, Anagnostopoulos, A. Athanasiadou 

Hematol Oncol. 2011 Sep;29(3):161-3 

Transient monoclonal CD3+ T large granular lymphocyte proliferation in a case of mantle cell lymphoma with Rituximab-associated late onset neutropenia 

Stalika, A. Papalexandri, G. Kannelis, I. Batsis, T. Papadaki, A. Anagnostopoulos, K. Stamatopoulos 

Hematol Oncol. 2011 Sep;29(3):144-6 

RUNX1-MTG16 fusion gene in de novo acute myeloblastic leukemia with t (16; 21) (q24; q22) 

Athanasiadou, E. Stalika, V. Sidi, M. Papaioannou, M. Gaitatzi, A. Anagnostopoulos 

Leuk Lymphoma. 2011 Jan;52(1):145-7 

Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: implications for the origin and selection of the malignant cells 

Agathangelidis, A. Hadzidimitriou, R. Rosenquist, K. Stamatopoulos 

Semin Cancer Biol 2011 Nov; 21(5):299-307 

Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases 

Hadzidimitriou, A. Agathangelidis A, N. Darzentas, F. Murray, M.H. Delfau-Larue, L. B. Pedersen, A.N. Lopez, A. Dagklis, P. Rombout, K. Beldjord, A. Kolstad, M. Dreyling, A. Anagnostopoulos, A. Tsaftaris, P. Mavragani-Tsipidou, A. Rosenwald, M. Ponzoni, P. Groenen, P. Ghia, B. Sander, T. Papadaki, E. Campo, C. Geisler, R. Rosenquist, F. Davi, C. Pott, K. Stamatopoulos 

Blood 2011 Sep 15; 118(11): 3088-95 

Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenetic significance in specific subsets of patients 

Arvaniti, S. Ntoufa, N. Papakonstantinou, T. Touloumenidou, N. Laoutaris, A. Anagnostopoulos, K. Lamnissou, F. Caligaris-Cappio, K. Stamatopoulos, P. Ghia 

Haematologica 2011, 96(11): 1644-52 

Sequential transient novel chromosomal translocations in a patient with Chronic Myelogenous Leukemia in Complete Cytogenetic Remission after therapy with Imatinib Mesylate 

Papaioannou, A. Athanasiadou, G. Voutiadou, M. Gaitatzi, I. Batsis, T. Touloumenidou, A. Anagnostopoulos 

Cancer Genetics 2011 Dec;204(12):692-3 

Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways 

M.A. Berkowska, G.J. Driessen, V. Bikos, C. Grosserichter-Wagener, K. Stamatopoulos, A. Cerutti, B. He, K. Biermann, J.F. Lange, M. van der Burg, J.J. van Dongen, M.C. van Zelm 

Blood 2011 Aug 25; 118(8): 2150-8 

Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases 

A.W. Langerak, F. Davi, P. Ghia, A. Hadzidimitriou, F. Murray, K.N. Potter, R. Rosenquist, K. Stamatopoulos, C. Belessi; European Research Initiative on CLL (ERIC) 

Leukemia 2011 Jun; 25(6):979-84 

The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 

Rossi, V. Spina, C. Deambrogi, S. Rasi, L. Laurenti, K. Stamatopoulos, L. Arcaini, M. Lucioni, G.B. Rocque, Z.Y. Xu-Monette, C. Visco, J. Chang, E. Chigrinova, F. Forconi, R. Marasca, C. Besson, T. Papadaki, M. Paulli, L.M. Larocca, S.A. Pileri, V. Gattei, F. Bertoni, R. Foa, K.H. Young, G. Gaidano 

Blood 2011 Mar 24; 117(12):3391-401 

Transient monoclonal CD3+ T large granular lymphocyte proliferation in a case of mantle cell lymphoma with Rituximab-associated late onset neutropenia 

Stalika, A. Papalexandri, G. Kannelis, I. Batsis I, T. Papadaki, A. Anagnostopoulos, K. Stamatopoulos 

Hematol Oncol 2011 Sep; 29(3):144-6 

Derivative (1;7)(q10;p10) in two patients with myelodysplastic syndrome after autologous haematopoietic cell transplantation 

Papaioannou, I. Batsis, F. Iordanidis, C. Vadikoliou, P. Kaloyannidis, A. Anagnostopoulos, A. Athanasiadou 

Hematol Oncol 2011Sep;29(3):161-3 

Treatment of acute promyelocytic leukemia with high white cell blood counts 

Kelaidi, L. Adès, P. Fenaux 

Mediterr J Hematol Infect Dis 2011; 3(1):e2011038 

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS 

S. Park, R. Sapena, C. Kelaidi, D. Vassilieff, D. Bordessoule, A. Stamatoullas, S. Cheze, O. Beyne-Rauzy, N. Vey, C. Rose, A. Guerci, S. Natarajan-Amé, G. Tertian, B. Slama, P. Fenaux, F. Dreyfus 

Leuk Res 2011 Nov;35(11):1530-3 

Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion–the GFM experience 

F. Le Bras, M. Sebert, C. Kelaidi, T. Lamy, F. Dreyfus, J. Delaunay, A. Banos, M. Blanc, N. Vey, A. Schmidt, S. Visanica, V. Eclache, P. Turlure, O. Beyne-Rauzy, A. Guerci, A. Delmer, S. de Botton, D. Rea, P. Fenaux, L. Adès 

Leuk Res. 2011 Nov; 35(11):1444-8 

Cytogenetic abnormalities in myelodysplastic syndromes: Clinical and prognostic impact 

Κelaidi, C. Sabani 

Haema 2011; 2(2): 177-186

Δημοσιεύσεις εργασιών 2010

A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence 

N. Darzentas, A. Hadzidimitriou, F. Murray, K. Hatzi, P. Josefsson, N. Laoutaris, C. Moreno, A. Anagnostopoulos, J. Jurlander, A. Tsaftaris, N.  Chiorazzi, C. Belessi, P. Ghia, R. Rosenquist, F. Davi, K. Stamatopoulos 

Leukemia2010 Jan; 24(1):125-32 

Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia 

F. Marantidou, A. Dagklis, S. Stalika, P. Korkolopoulou, A. Saetta, A. Anagnostopoulos, Ν. Laoutaris, K. Stamatopoulos, C. Belessi, Z. Scouras, E. Patsouris 

Blood Cells Mol Dis 2010 Apr 15;44(4):262-7 

Mobilization of hematopoietic stem cells in a thalassemic mouse model: implications for gene therapy of thalassemia 

E. Yannaki, N. Psatha, E. Athanasiou, G. Karponi, V. Constantinou, A. Papadopoulou, A. Tasouli, P. Kaloyannidis, I. Batsis, M. Arsenakis, A. Anagnostopoulos, A. Fassas 

Hum Gene Ther 2010 Mar;21(3):299-310 

The impact of Desferrioxamine post allogeneic hematopoietic cell transplantation in relapse P incidence and disease-free survival: a retrospective analysis 

P. Kaloyannidis, E. Yannaki, I. Sakellari, E. Bitzioni, A. Athanasiadou, D. Mallouri, A. Anagnostopoulos 

Transplantation 2010 Feb 27;89(4):472-9 

The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats 

E. Yannaki, A. Papadopoulou, E. Athanasiou, P. Kaloyannidis, A. Paraskeva, D. Bougiouklis, P. Palladas, M. Yiangou, A. Anagnostopoulos 

Arthritis and Rheumatism 2010 Nov;62(11):3277-88 

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases 

Farge, M. Labopin, A. Tyndall, A. Fassas, GL Mancardi, J. Van Laar, J. Ouyang, T. Kozak, J. Moore, I. Kotter, V. Chesnel, A. Marmont, A. Gratwohl, R. Saccardi 

Haematologica 2010 Feb;95(2):284-92 

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group 

Tsagarakis NJ, Kentrou NA, Papadimitriou KA, Pagoni M, Kokkini G, Papadaki H, Pappa V, Marinakis T, Anagnostopoulos NI, Vadikolia C, Anagnostopoulos A, Angelopoulou MK, Terpos E, Poziopoulos C, Anargyrou K, Rontogianni D, Papadaki T, Psarra A, Kontopidou FN, Skoumi D, Papadhimitriou SI, Paterakis G; Hellenic Dendritic Cell Leukemia Study Group 

Leuk Res 2010 Apr; 34(4):438-46 

GVL effect in plasmacytoid DC leukemia/lymphoma 

P. Kaloyannidis, A. Zomas, G. Paterakis, C. Vadikoliou, D. Mallouri, L. Sakkas, I. Sakellari 

Bone Marrow Transplant 2010 May;45(5):961-2 

Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia 

F. Marantidou, A. Dagklis, E. Stalika, P. Korkolopoulou, A. Saetta, A. Anagnostopoulos, N. Laoutaris, K. Stamatopoulos, C. Belessi, Z. Scouras, E. Patsouris 

Blood Cells Mol Dis. 2010 Apr 15; 44(4):262-7 

T-cell receptor Vβ repertoire analysis in patients with chronic idiopathic neutropenia demonstrates the presence of aberrant T-cell expansions 

M. Spanoudakis, H. Koutala, M. Ximeri, K. Pyrovolaki, K. Stamatopoulos, H.A. Papadaki 

Clin Immunol. 2010 Dec; 137(3):384-95 

Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors 

M. Marincevic, L. Mansouri, M. Kanduri, A. Isaksson, H. Goransson, K.E. Smedby, J. Jurlander, G. Juliusson, F. Davi, K. Stamatopoulos, R. Rosenquist 

Haematologica 2010 Dec; 95(12):2072-9 

Coexistence of different types of biallelic immunoglobulin heavy variable gene replacement events in a case of pediatric B precursor acute lymphoblastic leukemia 

Hadzidimitriou, N. Darzentas, A. Karakoli, D. Koliouskas, A. Tsaftaris, A. Anagnostopoulos, K. Stamatopoulos 

Leuk Lymphoma. 2010 Sep; 51(9):1748-50 

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group 

M. Salido, C. Baro, D. Oscier, K. Stamatopoulos, J. Dierlamm, E. Matutes, A. Traverse-Glehen, F. Berger, P. Felman, C. Thieblemont, S. Gesk, A. Athanasiadou, Z. Davis, A. Gardiner, F. Milla, A. Ferrer, M. Mollejo, M.J. Calasanz, L. Florensa, B. Espinet, E. Lujo, I. Wlodarska, G. Verhoef, M. Garcia-Granero, A. Salar, T. Papadaki, S. Serrano, M.A. Piris, F. Sole 

Blood 2010 Sep 2; 116(9):1479-88 

Antigens in CLL: themes and variations 

K. Stamatopoulos 

Blood 2010 May 13; 115(19):3855-6 

Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution 

Kostareli, L.A. Sutton, A. Hadzidimitriou, N. Darzentas, A. Kouvatsi, A. Tsaftaris, A. Anagnostopoulos, R. Rosenquist, K. Stamatopoulos 

Leukemia 2010 Jul; 24(7):1317-24 

High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with ‘stereotyped’ IGHV3-21 and IGHV4-34 B-cell receptors 

M. Marincevic, Cahill N, Gunnarsson R, Isaksson A, Mansouri M, Goransson H, Rasmussen M, Jansson M, Ryan F, Karlsson K, Adami HO, F. Davi, Jurlander J, Juliusson G, K. Stamatopoulos, R. Rosenquist 

Haematologica 2010 Sep; 95(9):1519-25 

The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL 

Forconi, K.N. Potter, I. Wheatley, N. Darzentas, E. Sozzi, K. Stamatopoulos, C.I. Mockridge, G. Packham, F.K. Stevenson 

Blood 2010 Jan 7; 115(1):71-7 

Gene therapy for β-thalassaemia: the continuing challenge 

Yannaki, DW. Emery, G. Stamatoyannopoulos 

Expert Rev Mol Med. 2010 Oct 1; 12:e31 

Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease 

E. Yannaki, G. Stamatoyannopoulos 

Ann N Y Acad Sci. 2010 Aug; 1202:59-63 

Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia 

M. Sadelain, I. Rivière, X. Wang, F. Boulad, S. Prockop, P. Giardina, A.Maggio, R. Galanello, F.Locatelli, E. Yannaki 

Ann N Y Acad Sci. 2010 Aug; 1202:52-8 

Reversible painful oral mucosal hyperpigmentation following palifermin administration 

P. Kaloyannidis, A. Papalexandri, E. Papaemanouil, M. Papaioannou, I. Sakellari 

Acta Haematol. 2010; 124(3):185-7 

Outbreak of novel influenza A (H1N1) in an adult haematology department ant haematopoietic cell transplantation unit: clinical presentation and outcome 

Lalayanni, A. Syrigou, M. Iskas, C. Smias, I. Sakellari, A. Anagnostopoulos 

Journal of Infection 2010; 61: 270-272 

On the estimation of the necessary inventory for Hellenic public cord blood banks using simulation 

Vlachos, E. Iakovou, C. Keramydas, A. Anagnostopoulos 

Oper Res Int J 2010 on line 20 October 

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group 

NJ. Tsagarakis, NA. Kentrou, KA. Papadimitriou, M. Pagoni, G. Kokkini, H. Papadaki, V. Pappa, T. Marinakis, NI. Anagnostopoulos, C. Vadikolia, A. Anagnostopoulos, MK. Angelopoulou, E. Terpos, C.  Poziopoulos, K. Anargyrou, D. Rontogianni, T. Papadaki, A. Psarra, FN.  Kontopidou, D. Skoumi, SI. Papadhimitriou, G. Paterakis; Hellenic Dendritic Cell Leukemia Study Group 

Leuk Res 2010 Apr; 34(4):438-46 

Risks of immune system treatments 

RK. Burt, M. Abinun, D. Farge-Bancel, A. Fassas, F. Hiepe, E. Havrdová, S. Ikehara, Y. Loh, A. Marmont du Haut Champ, JC. Voltarelli, J. Snowden, S. Slavin 

Science 2010 May 14; 328(5980):825-6 

Granulocyte colony stimulating factor-induced exacerbation of fungus-related immune restoration inflammatory syndrome: a case of chronic disseminated candidiasis exacerbation 

MO Chandesris, C Kelaidi, F Méchaï, ME Bougnoux, N Brousse, JP Viard, S Poirée, M Lecuit, O Hermine, O Lortholary 

J Microbiol Immunol Infect. 2010 Aug; 43(4):339-43 

Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: a retrospective analysis on 112 patients 

Spark, C. Kelaidi, R. Sapena, D. Vassilieff, O. Beyne-Rauzy, V. Coiteux, N. Vey, C. Ravoet, S. Cheze, C. Rose, L. Legros, A. Stamatoullas, M. Escoffre-Barbe, A. Guerci, MP. Chaury, P. Fenaux, F. Dreyfus 

Leuk Res. 2010 Nov; 34(11):1430-6 

Darbepoetin alfa in anemia of myelodysplastic syndromes: present and beyond 

Kelaidi, P. Fenaux 

Expert Opin Biol Ther 2010 Apr; 10(4):605-14 

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies 

Kelaidi, A. Stamatoullas, O. Beyne-Rauzy, E. Raffoux, B. Quesnel, A. Guerci, F. Dreyfus, S. Brechignac, C. Berthou, T. Prebet, Y. Hicheri, M. Hacini, J. Delaunay, MP. Gourin, JM. Camo, H. Zerazhi, AL. Taksin, L. Legros, B. Choufi, P. Fenaux; Groupe Francophone des Myélodysplasies 

Haematologica 2010 Jun; 95(6):892-9 

PML-RARalpha ligand-binding domain deletion mutations associated with reduced disease control and outcome after first relapse of APL 

Schachter-Tokarz, C. Kelaidi, B. Cassinat, C. Chomienne, C. Gardin, E. Raffoux, H. Dombret, P. Fenaux, R. Gallagher 

Leukemia 2010 Feb; 24(2):473-6

Δημοσιεύσεις εργασιών 2009

Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia 

Hadzidimitriou, N. Darzentas, F. Murray, T. Smilevska, E. Arvaniti, C. Tresoldi, A. Tsaftaris, N. Laoutaris, A. Anagnostopoulos, F. Davi, P. Ghia, R. Rosenquist, K. Stamatopoulos, C. Belessi 

Blood 2009 Jan 8; 113(2):403-11 

Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors 

E. Kostareli, A. Hadzidimitriou, N. Stavroyianni, N. Darzentas, A. Athanasiadou, M. Gounari, V. Bikos, A. Agathagelidis, T. Touloumenidou, I. Zorbas, A. Kouvatsi, N. Laoutaris, A. Fassas, A. Anagnostopoulos, C. Belessi, K. Stamatopoulos 

Leukemia 2009 May;23(5):919-24 

Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia 

Hadzidimitriou, N. Darzentas, F. Murray, T. Smilevska, E. Arvaniti, C. Tresoldi, A. Tsaftaris, N. Laoutaris, A. Anagnostopoulos, F. Davi, P. Ghia, R. Rosenquist, K. Stamatopoulos, C. Belessi 

Blood 2009 Jan 8;113(2):403-11 

The immunoglobulin gene repertoire of low-count CLL-like MBL is different from CLL: diagnostic implications for clinical monitoring 

Dagklis, C. Fazi, C. Sala, V. Cantarelli, C. Scielzo, R. Massacane, D. Toniolo, F. Caligaris-Cappio, K. Stamatopoulos, P. Ghia 

Blood 2009 Jul 2;114(1):26-32 

The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring 

Dagklis, C. Fazi, C. Sala, V. Cantarelli, C. Scielzo, R. Massacane, D. Toniolo, F. Caligaris-Cappio, K. Stamatopoulos, P. Ghia 

Blood 2009 Jul 2; 114(1):26-32 

Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors 

E. Kostareli, A. Hadzidimitriou, N. Stavroyianni, N. Darzentas, A. Athanasiadou, M. Gounari, V. Bikos, A. Agathagelidis, T. Touloumenidou, I. Zorbas, A. Kouvatsi, N. Laoutaris, A. Fassas, A. Anagnostopoulos, C. Belessi, K. Stamatopoulos 

Leukemia 2009 May; 23(5):919-24 

CLL: promiscuity leads to risks 

K. Stamatopoulos 

Blood 2009 Oct 22; 114(17):3508-9 

Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen 

LA. Sutton, E. Kostareli, A. Hadzidimitriou, N. Darzentas, A. Tsaftaris, A. Anagnostopoulos, R. Rosenquist, K. Stamatopoulos 

Blood 2009 Nov 12; 114(20):4460-8 

Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia 

Hadzidimitriou, N. Darzentas, F. Murray, T. Smilevska, E. Arvaniti, C. Tresoldi, A. Tsaftaris, N. Laoutaris, A. Anagnostopoulos, F. Davi, P. Ghia, R. Rosenquist, K. Stamatopoulos, C. Belessi 

Blood 2009; 113: 403-411 

Establishment of an animal model for Waldeström’s macroglobulinemia 

Tsingotjidou, C. Emmanouilidis, E. Siotou, T. Poutahidis, A. Xagorari, P. Loukopoulos, D. Sotiropoulos, C. Bekiari, M. Doulberis, P. Givissis, A. Fassas, A. Anagnostopoulos 

Exp Hematology 2009; 37:469-476 

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 

F. Ciceri, C. Bonini, M. T. Lupo Stanghellini, A. Bondanza, C. Traversari, M. Solomoni, L. Turchetto, S. Colombi, M. Bernandi, J. Peccatori, A. Pescarolo, P. Servida, Z. Magnani, S. Perna, V. Valtolina, F. Crippa, L. Callegano, E. Spoldi, R. Crocchiolo, K. Fleischhauer, M. Ponzoni, L. Vago, A. Sandoro, S. Rossini, E. Todisco, J. Apperley, E. Olavarria, S. Slavin, E. Weissinger, A. Ganser, M. Stadler, E. Yannaki, A. Fassas, A. Anagnostopoulos, M. Bregni, C. Stampino, P. Bruzzi, C. Bordignon 

Lancet Oncology 2009; 10 (5): 489-500

Δημοσιεύσεις εργασιών 2008

A unique case of IgD-only Splenic marginal-zone lymphoma with mutated immunoglobulin genes: Ontogenic implications 

T. Papadaki, K. Stamatopoulos, T. Mavrommatis, A. Anagnostopoulos, D. Anagnostou 

Leukemia Research 2008; 32: 155-157 

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome 

V. Kimiskidis, I. Sakellari, V. Tsimourtou, V. Kapinas, S. Papagiannopoulos, D. Kazis, N. Vlaikidis, A. Anagnostopoulos, A. Fassas 

Mult Scler 2008 Mar;14(2):278-83 

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis 

Murray, N. Darzentas, A. Hadzidimitriou, G. Tobin, M. Boudjogra, C. Scielzo, N. Laoutaris, K. Karlsson, F. Baran-Marzsak, A. Tsaftaris, C. Moreno, A. Anagnostopoulos, F. Caligaris-Cappio, D. Vaur, C. Ouzounis, C. Belessi, P. Ghia, F. Davi, R. Rosenquist, K. Stamatopoulos 

Blood 2008 Feb 1;111(3):1524-33 

Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors 

Chiotoglou, T. Smilevska, M. Samara, S. Likousi, C. Belessi, I. Athanasiadou, N. Stavroyianni, S. Samara, N. Laoutaris, A. Anagnostopoulos, A. Fassas, K. Stamatopoulos, P. Kollia 

Blood Cells Molecules and Diseases, Sep-Oct 2008;41(2):203-9 

Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia 

K. Stamatopoulos, T. Papadaki, C. Pontikoglou, I. Athanasiadou, N. Stavroyianni, J. Bux, I. Batsis, K. Pyrovolaki, G. Paterakis, D. Anagnostou, A. Anagnostopoulos, H. Papadaki 

Leukemia. 2008 Jul;22(7):1446-9 

Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IGG-switched stereotyped immunoglobulins 

Athanasiadou, K. Stamatopoulos, M. Gaitatzi, N. Stavroyianni, A. Fassas, A. Anagnostopoulos 

Haematologica 2008; Mar;93(3):473-4 

A unique case of IgD-only splenic marginal-zone lymphoma with mutated immunoglobulin genes: Ontogenetic implications 

T. Papadaki, K. Stamatopoulos, T. Mavrommatis, A. Anagnostopoulos, D. Anagnostou 

Leuk Res 2008 Jan; 32(1):155-7 

Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia 

K.Stamatopoulos, T. Papadaki, C. Pontikoglou, I. Athanasiadou, N. Stavroyianni, J. Bux, I. Batsis, K. Pyrovolaki, G. Paterakis, D. Anagnostou, A. Anagnostopoulos, H. Papadaki 

Leukemia 2008 Jul; 22(7): 1446-9 

Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IGG-switched stereotyped immunoglobulins 

Athanasiadou, K. Stamatopoulos, M. Gaitatzi, N. Stavroyianni, A. Fassas, A. Anagnostopoulos 

Haematologica 2008, 2008 Mar; 93(3):473-4 

Chronic lymphocytic leukaemia: an immunobiology approach 

E. Kostareli, T. Smilevska, K. Stamatopoulos, A. Kouvatsi, A. Anagnostopoulos 

Srb Arh Celok Lek 2008 May-Jun; 136(5-6): 319-23 

Immunoglobulin kappa gene repertoire and somatic hypermutation patterns in follicular lymphoma 

T. Smilevska, E. Tsakou, A. Hadzidimitriou, V. Bikos, N. Stavroyianni, N. Laoutaris, A. Fassas, A. Anagnostopoulos, T. Papadaki, C. Belessi, K. Stamatopoulos 

Blood Cells Mol Dis 2008 Sep-Oct; 41(2): 215-8 

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis 

Murray, N. Darzentas, A. Hadzidimitriou, G. Tobin, M. Boudjogra, C. Scielzo, N. Laoutaris, K. Karlsson, F. Baran-Marzsak, A. Tsaftaris, C. Moreno, A. Anagnostopoulos, F. Caligaris-Cappio, D. Vaur, C. Ouzounis, C. Belessi, P. Ghia, F. Davi, R. Rosenquist, K. Stamatopoulos 

Blood 2008 Feb 1; 111(3): 1524-33 

Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors 

Chiotoglou, T. Smilevska, M. Samara, S. Likousi, C. Belessi, I. Athanasiadou, N. Stavroyianni, S. Samara, N. Laoutaris, N. Vamvakopoulos, A. Anagnostopoulos, A. Fassas, K. Stamatopoulos, P. Kollia 

Blood Cells Mol Dis 2008 Sep-Oct; 41(2): 203-9 

Novel chromosomal aberration in Philadelphia negative cells of a patient with chronic myelogenous leukemia treated with Dasatinib 

Athanasiadou, C. Lalayanni, G. Papaioannou, M. Gaitatzi, A. Fassas, A. Anagnostopoulos 

Leuk Lymphoma 2008; 49(5): 1012-3 

Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation 

P. Ghia, N. Chiorazzi, K. Stamatopoulos 

J Intern Med 2008 Dec; 264(6): 549-62 

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria 

E. Matutes, D. Oscier, C. Montalban, F. Berger, E. Callet-Bauchu, A. Dogan, P. Felman, V. Franco, E. Iannitto, M. Mollejo, T. Papadaki, E.D. Remstein, A. Salar, F. Solé, K. Stamatopoulos, C. Thieblemont, A. Traverse-Glehen, A. Wotherspoon, B. Coiffier, M.A. Piris 

Leukemia 2008 Mar; 22(3): 487-95 

Determination of IGHV gene mutational status in chronic lymphocytic leukemia: bioinformatics advances meet clinical needs 

F. Davi, R. Rosenquist, P. Ghia, C. Belessi, K. Stamatopoulos 

Leukemia 2008 Jan; 22(1): 212-4 

Low body mass index is an independent risk factor for transplant-associated microangiopathy following total-body-irradiation-based conditioning regimens 

P. Kaloyannidis, D. Mallouri, K. Hatziioannou, I. Batsis,E. Yannaki, P. Papavasileiou, I. Sakellari 

Biol Blood Marrow Transpl 2008; 14: 1076-1078 

Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile? 

Fassas, GL. Mancardi 

Autoimmunity 2008 Dec;41(8):601-10

Δημοσιεύσεις εργασιών 2007

Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody disappearance post transplant, regardless of adoptive immunity transfer 

P. Kaloyannidis. I. Batsis, E. Yannaki, D. Adamidou, D. Bartzoudis, M. Papathanasiou, D. Mallouri, I. Sakellari, A. Fassas, A. Anagnostopoulos 

Biology of Blood and Marrow Transplantation 2007; 13: 1049-1056 

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations 

K. Stamatopoulos, C. Belessi,  C. Moreno, M. Boudjograh, G. Guida, T. Smilevska, L. Belhoul, S. Stella, N. Stavroyianni, M. Crespo, A. Hadzidimitriou, L. Sutton, F. Bosch, N. Laoutaris, A. Anagnostopoulos, E. Montserrat, A. Fassas, G. Dighiero, F. Caligaris-Cappio, H. Merle-Beral, P. Ghia, F. Davi 

Blood 2007; 109: 267-278 

Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases 

T. Papadaki, K. Stamatopoulos, C. Belessi, E. Pouliou, A. Parasi, V. Douka, N. Laoutaris, A. Fassas, A. Anagnostopoulos, D. Anagnostou 

Am J Surg Pathol 2007; 31: 438-46 

Reply to ‘Male preponderance in chronic lymphocytic leukemia utilizing IGHV1-69’ When size of the sample matters 

P. Ghia, C. Belessi, F. Davi, R. Rosenquist, K. Stamatopoulos 

Leukemia 2007 Dec; 21(12):2539-40 

Large granular lymphocyte leukemia after renal transplantation: an immunologic, immunohistochemical and genotypic study 

K. Stamatopoulos, D. Economidou, T. Papadaki, C. Vadikolia, M. Papathanasiou, D. Memmos, A. Fassas 

Transplantation 2007 Jan 15; 83(1):102-103 

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia 

P. Ghia, K. Stamatopoulos, C. Belessi, C. Moreno, S. Stilgenbauer, F. Stevenson, F. Davi, R. Rosenquist 

Leukemia 2007 Jan; 21(1):1-3 

Expert opinion: guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies 

R. Gold, A. Jawad, DH Miller, DC. Henderson, A. Fassas, W. Fierz, HP. Hartung J Neuroimmunol 2007; 187: 156-8 

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party 

Schmid, M. Labopin, A. Nagler, M. Bornhäuser, J. Finke, A. Fassas, L. Volin, G. Gürman, J. Maertens, P. Bordigoni, E. Holler, G. Ehninger, E. Polge, NK. Gorin, HJ. Kolb, V. Rocha 

J Clin Oncol 2007; 25: 4938-45

Δημοσιεύσεις εργασιών 2006

Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia 

T. Smilevska, K. Stamatopoulos, M. Samara, C. Belessi, A. Tsompanakou, G. Paterakis, N. Stavroyianni, I. Athanasiadou, I. Ciotoglou, A. Hatzidimitriou, A. Athanasiadou, V. Douka, R. Saloum, N. Laoutaris, A. Anagnostopoulos, A. Fassas, P. Kollia 

Leukemia Research 2006; 30(2):183-189 

IGHV gene insertions and deletions in chronic Lymphocytic leukaemia: “CLL-biased” deletions in a subset of cases with stereotyped receptors 

Belessi, F. Davi, K. Stamatopoulos, M. Degano, T. Andreou, C. Moreno, H. Merle-Beral, M. Crespo, N. Laoutaris, E. Montserrat, F. Caligaris-Cappio, A. Anagnostopoulos, P. Ghia 

European Journal of Immunology 2006; 36: 1963-1074 

Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases 

Hadzidimitriou, K. Stamatopoulos, C. Belessi, C. Lalayianni, N. Stavroyianni, T. Smilevska, K. Hatzi, N. Laoutaris, A. Anagnostopoulos, P. Kollia, A. Fassas. 

Haematologica. 2006; 91(6):781-7 

Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukaemia in the routine flow cytometry setting: a methodological approach 

F. Passam, V. Tachynopoulou, D. Skoumi, A. Tsompanakou, A. Stavropoulos-Giokas, C. Vadikolia, A. Anagnostopoulos, G. Paterakis 

Ann Hematol 2006; 85(11):795-805. Epub 2006 Jul 27 

Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukaemia and comparison with other karyotypic subgroups defined by cytogenetic analysis 

Athanasiadou, K. Stamatopoulos, A. Tsompanakou, M. Gaitatzi, P. Kalogiannidis, A. Anagnostopoulos, A. Fassas, A. Tzezou 

Cancer Genetics and Cytogenetics 2006; 168: 109-119 

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations 

K. Stamatopoulos, C. Belessi, C. Moreno, M. Boudjograh, G. Guida, T. Smilevska, L. Belhoul, S. Stella, N. Stavroyianni, M. Crespo, A. Hadzidimitriou, L. Sutton, F. Bosch, N. Laoutaris, A. Anagnostopoulos, E. Montserrat, A. Fassas, G. Dighiero, F. Caligaris-Cappio, H. Merle-Beral, P. Ghia, F. Davi 

Blood 2007Jan 1;109(1):259-70. Epub 2006 Sep 19 

Report of novel chromosomal abnormalities in a series of 130 chronic lymphocytic leukemia patients studied by classic cytogenetic analysis 

Athanasiadou, K. Stamatopoulos, A. Tsezou, C. Vadikolia, O. Asteriou, A. Fassas, A. Anagnostopoulos 

Leukemia and Lymphoma 2006; Oct;47(10):2084-7 

Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells 

Yannaki, A. Anagnostopoulos, D. Kapetanos, A. Xagorari, F. Iordanidis, I. Batsis, P. Kaloyannidis, E. Athanasiou, G. Dourvas, G. Kitis, A. Fassas 

Experimental Hematology 2006; 34: 1583-1587 

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens 

Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, Fassas A, Snowden  J, Schuening F, Myint H, Patel DD, Collier D, Heslop H, Krance R, Statkute L, Verda L, Traynor A, Kozak T, Hintzen RQ, Rose JW, Voltarelli J, Loh Y, Territo M, Cohen BA, Craig RM, Varga J, Barr WG 

Arthritis Rheum 2006; 54: 3750-60 

Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database 

Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E, Carreras E, Saiz A, Lowenberg B, te Boekhorst PA, Gualandio F, Openshaw H, Longo G, Pagliai F, Massacesi L, Deconink E, Ouyang J, Nagore FJ, Besalduch J, Lisukov IA, Bonini A, Merelli E, Slavino S, Gratwohl A, Passweg J, Tyndall A, Steck AJ, Andolina M, Capobianco M, Martin JL, Lugaresi A, Meucci G, Saez RA, Clark RE, Fernandez MN, Fouillard L, Hertenstein B, Koza V, Cocco E, Baurmann H, Mancardi GL 

Mult Scler 2006; 12: 814-23 

Γονιδιακή Θεραπεία για τη Μεσογειακή Αναιμία: από το πειραματικό στάδιο στην κλινική εφαρμογή 

Γιαννάκη 

ΒΙΟReport 2006;19:2-5 

Large granular lymphocyte leukemia after renal trasplantation: an immunologic, immunohistochemical and genotypic study 

Stamatopoulos K, Economidou D, Papadaki T, Vadikolia C, Papathanasiou M, Memmos D, Fassas A 

Transplantation 2007 Jan 15;83(1):102-103 

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia 

Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stilgenbauer S, Stevenson F, Davi F, Rosenquist R 

Leukemia 2007 Jan;21(1):1-3

Δημοσιεύσεις εργασιών 2005

Report of two novel chromosomal translocations in chronic lymphocytic leukemia 

Athanasiadou, K. Stamatopoulos, A. Tsompanakou, D. Foutsitsakis, A. Fassas, A. Anagnostopoulos, A. Tsezou 

Leukemia & Lymphoma 2005; 46(1): 133-136 

G-CSF-primed hematopoietic stem cells or G-CSG per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs 

E. Yannaki, E. Athanasiou, A. Xagorari, V. Konstantinou, I. Batsis, P. Kaloyannidis, E. Proya, A. Anagnostopoulos, A. Fassas 

Experimental Hematology 2005; 33: 108-119 

Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia 

H. Papadaki, K. Stamatopoulos, A. Damianaki, C. Gemetzi, A. Anagnostopoulos, T. Papadaki, A. Eliopoulos, G. Eliopoulos 

British Journal of Haematology 2005; 128: 863-876 

The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia 

Fassas and A. Anagnostopoulos 

Leukemia & Lymphoma 2005; 46:795-802 

Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene 

P. Ghia, K. Stamatopoulos, C. Belessi, C. Moreno, S. Stella, G. Guida, A. Michel, M. Crespo, N. Laoutaris, E. Monserrat, A. Anagnostopoulos, G. Dighiero, A. Fassas, F. Caligaris-Cappio, and F. Davi 

Blood 2005; 105: 1678-1685 

Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases 

M. Somali, V. Mpatakoias, A. Avramides, I. Sakellari, P. Kaloyannidis, C. Smias, A. Anagnostopoulos, A. Kourtis, D. Rousso, D. Panidis, A. Vagenakis 

Gynecol Endocrinol. 2005; 21(1):18-26 

Immunoglobulin light chain repertoire in chronic lymphocytic leukemia 

K. Stamatopoulos, C. Belessi, A. Hatzidimitriou, T. Smilevska, E. Kalagiakou, K. Hatzi, N. Stavroyianni, A. Athanasiadou, A. Tsompanakou, T. Papadaki, G. Kokkini, G. Paterakis, R. Saloum, N. Laoutaris, A. Anagnostopoulos, A. Fassas 

Βlood 2005; 106: 3575-3583 

Thyroid dysfunction in adult long-term survivors after hemapoietic stem cell transplantation 

M. Somali, V. Mpatakoias, A. Avramides, I. Sakellari, C. Smias, A. Anagnostopoulos, A. Papachristou, A. Antoniadou 

Horm Metab Res 2005; 37 (8): 494-499 

Veno-occlusive disease prophylaxis with fresh frozen plasma and heparin in bone marrow transplantation 

Batsis, E. Yannaki, P. Kaloyannidis, I. Sakellari, C. Smias, I. Georgoulis, A. Fassas, A. Anagnostopoulos 

Thromb Res 2006;118(5):611-8. Epub 2005 Dec 5 

Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis 

Papadaki HA, Tsagournisakis M, Mastorodemos V, Pontikoglou C, Damianaki A, Pyrovolaki K, Stamatopoulos K, Fassas A, Plaitakis A, Eliopoulos GD. 

Bone Marrow Transplant2005; 36: 1053-1063 

Autologous hematopoietic stem cell transplantation for autoimmune diseases 

Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kotter I, Kozak T, Lisukov I, Lowenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A 

Bone Marrow Transplant 2005; 35: 869-79 

Analysis of Expressed and Non-Expressed IGK Locus Rearrangements in Chronic Lymphocytic Leukemia 

Belessi, K. Stamatopoulos, A. Hadzidimitriou, K. Hatzi, T. Smilevska, N. Stavroyianni, F. Marantidou, G. Paterakis, A. Fassas, A. Anagnostopoulos, N. Laoutaris 

Mol Med. 2005;11(1-12):52-8

Δημοσιεύσεις εργασιών 2004

Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic cell transplantation for Philadelphia-positive acute lympoblastic leukemia 

Athanasiadou, K. Stamatopoulos, I. Sakellari, I. Zorbas, M. Gaitatzi, A. Fassas, A. Anagnostopoulos 

Bone Marrow Transplant 2004; 34(2):189-91 

Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases 

Athanasiadou, N. Stavroyianni, R. Saloum, O. Asteriou, A. Anagnostopoulos, A. Fassas 

Leukemia 2004; 18: 1029-1030 

Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a 

P. Kaloyannidis, I. Sakellari, A. Fassas, T. Fragia, S. Vakalopoulou, C. Kartsios, B. Garypidou, V. Kimiskidis, A. Anagnostopoulos 

Bone Marrow Transplant 2004 Jul; 34(2):187-8 

Rituximab is effective for selected patients with chronic steroid-refractory immune thrombosytopenic purpura 

Lalayanni, N. Stavroyianni, R. Saloum, A. Tsompanakou, A. Anagnostopoulos 

Hematology 2004; 9(4): 287-289 

Transgenic Cre expression mice for generation of erythroid-specific gene alterations 

Peterson KR, Fedosyuk H, Zelenchuk L, Nakamoto B, Yannaki E, Stamatoyannopoulos G, Cicciotte S, Peters LL, Scott LM, Papayannopoulou T 

Genesis 2004;39(1):1-9 

Autologous stem cell transplantation for systemic lupus erythematosus 

Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R, Hiepe F, Lisukov I, Musso M, Ou-Yang J, Marsh J, Wulfraat N, Besalduch J, Bingham SJ, Emery P, Brune M, Fassas A, Faulkner M, Ferster A, Fiehn C, Fouillard L, Geromin A, Greinix H, Rabusin M, Saccardi R, Schneider P, Zintl F, Gratwohl A, Tyndall A; European Group for Blood and Marrow Transplantation; European League Against Rheumatism Registry 

Lupus 2004; 13: 168-76 

Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience 

Fassas A, Kimiskidis VK 

J Neurol Sciences 2004; 223: 53-58 

Stem cell transplantation for autoimmune disorders. Multiple sclerosis 

Fassas A, Nash R 

Best Pract Res Clin Haematol 2004; 17: 247-262 

The European randomized HSCT trial for multiple sclerosis 

Fassas A. 

Blood Marrow Transplant Reviews 2004; 14: 9-10 

Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis 

Saccardi R, Tyndall A, Coghlan G, Denton C, Edan G, Emdin M, Farge D, Fassas A, Finke J, Furst D, Lassus M, Mancardi G, Miniati I, Mini E, Pagliai F, Passweg J, Pignone A, van Laar JM, Bocelli-Tyndall C, Matucci-Cerinic M 

Bone Marrow Transplant 2004; 34: 877-881 

Immunoglobulin heavy- and light- chain repertoire in splenic marginal zone lymphoma 

K. Stamatopoulos, C. Belessi, T. Papadaki, E. Kalagiakou, N. Stavroyianni, V. Douka, S. Afentaki, R. Saloum, A. Parasi, D. Anagnostou, N. Laoutaris, A. Fassas, A. Anagnostopoulos 

Mol Med. Jul-Dec 2004;10(7-12):89-95

Δημοσιεύσεις εργασιών 2003

Therapeutic plasma exchange in patients with grade 2-3 hematopoietic stem cell transplantation- associated thrombotic thrombocytopenic purpura: A ten-year experience 

F. Christidou, A. Athanasiadou, P. Kaloyannidis, T. Natse, G. Bamichas, R. Saloum, I. Sakellari, A. Anagnostopoulos, A. Fassas, K. Sombolos 

Therapeutic Apheresis and Dialysis 2003; 7(2):259-262 

Safety of high-dose liposomal daunorubicin (Daunoxome) for refractory or relapsed acute myeloblastic leukaemia 

Fassas, R. Buffels, P. Kaloyannidis, A. Anagnostopoulos 

British Journal of Haematology 2003; 122: 161-163 

Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemia 

P. Kollia, M. Samara, K. Stamatopoulos, C. Belessi, N. Stavroyianni, A. 

Tsompanakou, A. Athanasiadou, N. Vamvakopoulos, N. Laoutaris, A. Anagnostopoulos, A. Fassas 

Leukemia Research 2003; 27 (12): 1101-1103 

Rituximab-associated immune myelopathy 

T. Papadaki, K. Stamatopoulos, A. Anagnostopoulos, A. Fassas 

Blood 2003; 102: 1557-1558 

Somatic hypermutation patterns in germinal center B cell malignancies 

K. Stamatopoulos, C. Belessi, T. Papadaki, N. Stavroyanni, A. Hadzidimitriou, C. Kosmas, N. Laoutaris, A. Fassas, A. Anagnostopoulos 

Hematology 2003; 8:319-328 

Κοκκιοκυτταρικό σάρκωμα (χλώρωμα) κεντρικού νευρικού συστήματος: Ευρήματα στην αξονική και μαγνητική τομογραφία 

Π. Παλλάδας, Δ. Βουλτσινού, Α. Πετρίδης, Ι. Σακελλάρη, Α. Αναγνωστόπουλος, Α. Δρεβελέγκας 

Ελληνική Ακτινολογία 2003; 34 (3): 237-243 

Spontaneous adrenal haemorrhage as a manifestation of isolated relapse of non-Hodgkin’s lymphoma 

C. Kartsios, P. Kaloyannidis, E. Yannaki, P. Iordanidis, V. Penopoulos, I.     Sakellari, A. Anagnostopoulos 

Acta Haematologica 2003;110:197-199 

Απεικονιστική προσέγγιση της νευροτοξικής δράσης της κυκλοσπορίνης 

Π. Παλλάδας, Δ. Βουλτσινού, Κ. Κουτρουμανίδης, Α. Αναγνωστόπουλος, Τ. Γερούκης 

Ελληνική Ακτινολογία 2003; 34 (4): 352-360 

Comparison of allogeneic stem cell transplantation, high dose cytarabine, and autologous peripheral stem cell transplantation as postremissiοn treatment in patients with de novo acute myelogenous leukemia 

Α. Tsimberidou, N. Stavroyianni, N. Viniou, M. Papaioannou, M. Tiniakou, T. Marinakis, A. Skandali, I. Sakellari, X. Yiataganas 

Cancer 2003; 97: 1721-1731 

Stem cell transplantation for multiple sclerosis: what is the evidence? 

Fassas, V. Kimiskidis 

Blood Reviews 2003; 17: 233-240 

High-dose immunosuppression and autologous hematopoietic stem cell rescue for severe multiple sclerosis 

Fassas, A. Kazis 

J Hematother & Stem Cell Res 2003; 12: 701-711 

Expression of recombination activating genes-1      and-2 immunoglobulin heavy chain gene rearrangements in acute myeloid leukemia: evaluation of biological and clinical significance in a series of 76 uniformly treated patients and review of the literature 

N. Stavroyianni, C. Belessi, K. Stamatopoulos, C. Kosmas, G. Paterakis, D. Abazis, C. Pangalos, X. Yataganas 

Haematologica 2003; 88: 268-274 

Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study 

P. Korkolopoulou, N. Viniou, N. Kavantzas, E. Patsouris, I. Thymara, PM. Pavlopoulos, E. Terpos, K. Stamatopoulos, E. Plata, K. Anargyrou, A. Androulaki, P. Davaris, X. Yataganas     

Leukemia 2003; 17: 89-97 

Hodgkin disease immunopathogenesis: long-standing questions, recent answers, further directions 

T. Papadaki, K. Stamatopoulos 

Trends Immunol 2003; 24: 508-511 

A unique case of splenic marginal zone-cell lymphoma with synchronous clonal           T-cell large granular lymphocyte proliferation: an immunologic, immunohistochemical and genotypic study 

T. Papadaki, K. Stamatopoulos, C. Kosmas, V. Kapsimali, T. Economopoulos 

Leuk Res 2003; 27: 85-87 

Clonal analysis of granulocyte-monocyte colony-forming unit cells with the human androgen receptor gene in chronic myeloid leukemia 

S. Akel, D. Mavroyanni, X. Yataganas, E. Terpos, J. Meletis, K. Anargyrou, N. Stavrogianni, G. Pangalis, D. Loukopoulos, N. Viniou 

Int J Hematol 2003; 77: 476-481 

Phase I-II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer 

Kosmas, N. Tsavaris, N. Malamos, N. Stavroyianni, A. Gregoriou, S. Rokana, A. Polyzos 

Br J Cancer 2003; 88: 1168-1174

Παλαιότερες δημοσιεύσεις εργασιών

Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia 

A Fassas, T Papageorgiou, A Kontodimou, E Proya, M Hadjikyrkou, A Anagnostopoulos 

J Chemother 1989 Jul;1(4 Suppl):1295-7 

Spontaneous remission of acute myeloid leukemia in a patient with concurrent Pneumocystis carinii pneumonia 

A Fassas, I Sakellari, A Anagnostopoulos, R Saloum 

Nouv Rev Fr Hematol 1991;33(5):363-4 

Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukaemia 

A Osterborg, A S Fassas, A Anagnostopoulos, M J Dyer, D Catovsky, H Mellstedt 

Br J Haematol 1996 Apr;93(1):151-3 

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study 

A Fassas, A Anagnostopoulos, A Kazis, K Kapinas, I Sakellari, V Kimiskidis, A Tsompanakou 

Bone Marrow Transplant 1997 Oct;20(8):631-8 

Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group 

G Comi, L Kappos, M Clanet, G Ebers, A Fassas, F Fazekas, M Filippi, H P Hartung, B Hertenstein, D Karussis, G Martino, A Tyndall, F G van der Meché 

J Neurol 2000 May;247(5):376-82 

Autologous stem cell transplantation in progressive multiple sclerosis–an interim analysis of efficacy 

Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, Smias C, Eleftheriadis N, Tsimourtou V 

J Clin Immunol 2000 Jan;20(1):24-30 

Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens 

E Athanasiou, V Kaloutsi, V Kotoula, P Hytiroglou, I Kostopoulos, C Zervas, P Kalogiannidis, A Fassas, J I Christakis, C S Papadimitriou 

Am J Clin Pathol 2001 Oct;116(4):535-42 

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study 

A Fassas  1 , J R Passweg, A Anagnostopoulos, A Kazis, T Kozak, E Havrdova, E Carreras, F Graus, A Kashyap, H Openshaw, M Schipperus, E Deconinck, G Mancardi, A Marmont, J Hansz, M Rabusin, F J Zuazu Nagore, J Besalduch, T Dentamaro, L Fouillard, B Hertenstein, G La Nasa, M Musso, F Papineschi, J M Rowe, R Saccardi, A Steck, L Kappos, A Gratwohl, A Tyndall, J Samijn, Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation) 

J Neurol 2002 Aug;249(8):1088-97 

Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study 

A Fassas, R Buffels, A Anagnostopoulos, E Gacos, C Vadikolia, P Haloudis, P Kaloyannidis 

Br J Haematol 2002 Feb;116(2):308-15